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ABSTRACT 
Tyrosinase (E.C. 1.14.18.1) is a key enzyme in the 
biosynthesis of melanin. The control of melanin sythesis was 
explored in skin melanocytes of the following strains; wild 
type (C57BL/6J-C/C) (which maximally synthesize melanin at 
normal mammalian body temperature, Himalayan (C57BL/6J-ch;ch) 
(which maximally synthesize melanin at temperatures below 
37°C) and albino (Balb c-c/c) (a mutant which does not 
synthesize melanin) 
The effect of a-MSH on tyrosinase activity was initially 
investigated. A skin culture tyrosinase assay that made it 
possible to measure the effect of a-MSH on the activity of 
this enzyme in vitro was first developed. It was found that 
a-MSH activated the wild type and Himalayan tyrosinase in a 
dose-dependent manner and that this activation did not 
require the de novo synthesis of new enzyme. 
The role of glycosylation on the wild type and particularly 
the Himalayan tyrosinase activity was next investigated. The 
results do not support, but are not in conflict with the 
theory that the Himalayan tyrosinase is inherently 
underglycosylated. 
xviii 
Translation and transcription as additional control 
mechanisms of tyrosinase activity was finally investigated. 
The correlation between the levels of tyrosinase activity, 
abundance of the enzyme and the synthesis of tyrosinase mRNA 
in wild type, Himalayan and albino mice was determined. It 
was shown that the levels of newly synthesized tyrosinase and 
tyrosinase mRNA transcripts were higher in the wild type than 
in the Himalayan skin. This could account for the reduced 
tyrosinase activity in the Himalayan mutant at normal body 
temperature. Low levels of tyrosinase mRNA were found in the 







The development of a fertilized egg into a mature organism 
does not simply produce a multicellular mass of identical 
cells. Instead, intracellular events leading to unique 
structural and functional products take place. At the 
molecular level, differential gene activity in different 
cells results in the synthesis of the specific proteins which 
are characteristic of the various cell types. 
While differentiated cells produce unique proteins, the 
mechanisms that control the synthesis of these end products 
are not so obvious. The mystery of the differentiative 
pathway has considerably deepened following the realization 
that different cells within the same organism have an 
identical and complete sets of genes. How tissue specific 
master genes direct the expression of mRNA in these different 
cell types remains to be elucidated. Since differentiated 
cells change the expression of their final product in 
response to various agents, it is still not clear how this 
process occurs and whether such changes are regulated at the 
level of transcription or post-transcription. 
To answer these questions, the present study has made use of 
the melanocyte, a pigment cell whose differentiated condition 
is characterized by the formation of melanin. A pigment cell 
3 
provides an ideal model system to study differentiation 
events, since melanin synthesis is catalyzed by a single key 
enzyme, tyrosinase, which can easily be assayed in vitro. 
Although melanin formation is primarily regulated by 
tyrosinase, how the synthesis and activity of this enzyme in 
particular are controlled by various endogenous and exogenous 
factors is poorly understood. In order to explore in depth 
the control mechanisms of tyrosinase activity, normal, mutant 
and transformed mouse melanocytes were used in this 
investigation 
1.2 ORIGIN AND DIFFERENTIATION OF MELANOCYTES 
The neural crest is a transient embryonic structure which 
gives rise to numerous and diverse derivatives including 
peripheral neurons, glial and Schwann cells, endocrine and 
pigment cells (Le Douarin, 1982). These cells migrate along 
various routes through the extra-cellular matrix to reach 
their destinations. Pigment cells migrate as large round 
amoeboid cells called melanoblasts via the sub-epidermal 
route to their final epidermal sites, where they become fully 
differentiated melanocytes (Mayer, 1973; Le Douarin, 1982; 
Nakayama et al., 1988) (Fig. 1.1). Melanocyte 
differentiation is characterized by dendrification (Prestin 





Fig. 1.1: Scheme showing the origin, migration and differentiation of melanocytes. e, epidermis; d, dermis; h, hair bulb. 
J>, 
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1966; Pawelek et al., 1973; Halaban et al., 1983; Bennett et 
al., 1986) and melanin deposition within melanosomes 
(Steinberg, 1976; Mufson, 1979; Hu et al., 1982). 
1.3 BIOCHEMISTRY OF MELANIN BIOSYNTHESIS 
Melanin is synthesized, within the melanosome, from the amino 
acid, tyrosine. The key enzyme in this biosynthetic pathway 
is tyrosinase (monophenol monooxygenase, E.C. 1.14.18.1 
(Hearing et al., 1980; Garcia-Canovas et al., 1982; Hearing & 
Jimenez, 1987). As shown in Figure 1.2., mammalian 
tyrosinase first catalyzes the hydroxylation of tyrosine to 
3,4-dihydroxyphenylalanine (DOPA) which is also a cofactor of 
this initial reaction (Nagatsu et al., 1964; Pomerantz, 1964, 
1966; Oikawa et al., 1972). The second catalytic step of 
tyrosinase is the oxidation of DOPA to DOPAquinone and 
subsequent steps resulting in melanin formation are thought 
to occur autocatalytically. Tyrosinase must therefore have 
at least three binding sites, one each for binding of 
tyrosine and DOPA as substrates and a third for the binding 
of DOPA as a cofactor (Pomerantz & Warner, 1967; Hearing & 
Ekel, 1976). In addition, recent evidence indicates that 
tyrosinase may also catalyze the oxidation of 5,6-
dihydroxyindole to indole-5,6-quinone (Korner & Pawelek, 
1982), suggesting that there might be a fourth binding site. 
6 
Tyrosine 
HOCGlHl I HC-COOH 
HO ~ N/ H 
Leucodopaquinone 
l 
Melanin p0lymer .-i o-o:~t CH 
o• / 
lodo~·S.6-a.'.:oo;ne i 5,6-Dihydroxyindole 
IBF 
Fig. 1.2: Scheme showing the melanin biosynthetic pathway 
and control steps distal to tyrosinase. (Based on studies as 
detailed in the text). Note the third reaction catalyzed by 
tyrosinase (i.e. 5,6-dihydroxyindole to indole-5,6-quinone) 
and the sites of action of IBF (indole blocking factor) and 
DCF (dopachrome conversion factor). 
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Even though the conversion of DOPAquinone to melanin is 
thought to be autocatalytic, another enzyme, dopachrome 
oxidoreductase (DCOR), a 34 kd protein (Barber et al., 1984), 
has been shown to catalyze the conversion of dopachrome to 
5,6-dihydroxyindole. This enzyme (DCOR), which is referred 
to by Hearing et al. (1981) as the dopachrome conversion 
factor (DCF), is closely associated with the catalytic 
activity of tyrosinase in vivo inside the melanosome. 
Most importantly, yet another factor termed the indole 
blocking factor (IBF), has been shown to affect melanin 
formation negatively by inhibiting the conversion of 5,6-
dihydroxyindole into indole-5,6-quinone. The indole blocking 
factor is thought to be an adaptation which prevents the 
premature formation of toxic melanin precursors in the 
cytoplasm. Thus, inside the melanosome, the site of melanin 
formation in vivo, the indole blocking factor is replaced by 
dopachrome conversion factor (Hearing et al., 1982). 
1.4 FACTORS THAT REGULATE TYROSINASE ACTIVITY 
Although tyrosinase is known to be the key enzyme involved in 
the biosynthesis of melanin in pigment cells, the question of 
how its activity is regulated still remains to be fully 
elucidated. Besides genetic factors, a number of parameters 
which regulate melanin synthesis by modulating the activity 
8 
of tyrosinase have been identified. These include exogenous 
factors such as: 
(1) Ultra-violet radiation in humans (Quevedo et al., 1965; 
Rosdal & Szabo, 1978; Rosen, 1987; and Lester et al., 
1988) . 
(2) Melanocyte stimulating hormone in mice (Burchill et al., 
1986; Seerchurn et al., 1988) and other mammals 
(Weatherhead & Logans, 1981). 
and endogenous factors like: 
(3) Inhibitors and activators of tyrosinase (Hearing, 1973; 
Chen, 1975; Korner & Pawelek, 1977; Korner & Pawelek, 
1980; Barber et al., 1984; Garcia-Boron et al., 1985; 
and Pawelek et al., 1980 Hearing et al., 1982). 
(4) Availability of substrates (Slominski et al., 1988) and 
cofactors (Hearing et al., 1978; Martinez et al., 1987) 
(5) Intra-melanosomal pH (Devi et al., 1987; Garcia-Canovas 
et al. , 1988) 
(6) Post-translational glycosylation (Hearing et al., 1981; 
Imokawa & Mishima, 1982; Imokawa & Mishima, 1983; 
Imokawa & Mishima, 1986; and Halaban et al., 1988). 
(8) Environmental temperature (Coleman, 1962; Chen & Chavin, 
1975; Kidson & Fabian, 1979; 1981; Halaban et al., 1988; 
Fernandez & Bagnara, 1989). 
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The relevant literature on some of the factors covered in 
this thesis will be discussed below and possible mechanisms 
action of these factors described. 
1.5 GENETIC CONTROL OF MELANIN SYNTHESIS 
The inheritance of coat color in mice was one of the first 
mammalian traits to be studied (Cuenot, 1905; Castle & 
Little, 1910). Since then, geneticists have attempted to 
identify genes that influence pigmentation. To date, 
significant progress has been made in this direction as more 
than 50 genetic loci that affect melanin formation have 
already been described (Bennett et al., 1989; Brilliant et 
al., 1989). This discussion will be restricted to the role 
of the~,~, Q and~ loci and their interactions during 
melanogenesis. 
The Q or albino locus, situated on chromosome 7, controls the 
availability of active tyrosinase and determines whether or 
not the melanin pigment is formed. One of the well described 
mutation at this locus is that of albinism, which is caused 
by undetectable or reduced levels of tyrosinase activity, 
resulting in the inability to synthesize melanin. The albino 
phenotype is therefore characterized by white coat color due 
to the absence of melanin in pigment cells (i.e. amelanotic 
melanocytes). Other known alleles of this locus include; the 
10 
Himalayan (ch), chinchilla (cch) and extreme dilution (ce) 
mutants mice. 
Previously, it was shown that the C/c heterozygotes of the F1 
generation displayed an intermediate coat color and 
tyrosinase activity when compared with their C/C and c/c 
homozygous parents (Coleman, 1962). This observation led to 
the assumption that the Q locus encodes the structural gene 
for the pigment synthesizing-enzyme tyrosinase (Silvers, 
1979; Kwon et al., 1987; Halaban et al., 1988; Ruppert et 
al., 1988). In contrast to this view, the finding that some 
albino mice and hamster species displayed significant levels 
of tyrosinase activity gave rise to the hypothesis that the Q 
locus does not code for the structural tyrosinase gene, but 
rather a regulatory protein involved in melanin formation 
(Hearing, 1973; Pomerantz and Li, 1974). In the light of 
this controversy, a lot of effort has been focused on 
generating DNA probes so as to perform a detailed analysis of 
the Q locus at the molecular level (Shibahara et al., 1986; 
Kwon et al., 1987, 1988; Ruppert et al., 1988). 
The first cDNA thought to code for tyrosinase, called pMT4, 
was isolated by Shibahara et al. (1986), but was later shown 
by Muller et al. (1988) to hybridize to genomic DNA of mice 
carrying large Q locus deletions. Furthermore, expression 
studies showed that the cDNA insert of pMT4 produced a 
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protein with no tyrosinase activity, suggesting that this is 
not the authentic tyrosinase gene. These findings suggested 
that the pMT4 cDNA, which was shown by Jackson (1988) to map 
to the~ locus, does not encode for tyrosinase. Recently, a 
number of genes which were mapped to the Q locus have been 
sequenced and cloned. These include cDNA's such as the 
pme134 (Kwon et al., 1987), MTY811 (Kwon et al., 1988), 
pmTyrl (Ruppert et al., 1988). These cDNA's are thought to 
code for tyrosinase because their corresponding genomic DNA 
has been shown to be absent in Q-locus deletion mice, but 
present in wild type mice. The transfection of these cDNA's 
into cells that do not normally synthesize melanin (e.g. 
breast cancer cell line, albino melanocytes, etc.) has been 
shown to confer tyrosinase activity on these cells (Muller et 
al., 1988; Yamamoto et al., 1989). These findings clearly 
show that the Q locus is the structural gene for tyrosinase. 
However, this conclusion has been challenged by Shibahara 
(1988) who by the Southern blot analysis showed that the 
genomic DNA from the Q-locus-deleted mice gives the same 
signal as that of wild type mice, suggesting that the Q locus 
does not code for tyrosinase. Thus, the question of whether 
the Q locus is the structural or regulatory tyrosinase gene 
still remains to be elucidated and may perhaps in future be 
resolved by the use of transgenic mice. 
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The A or agouti locus situated on chromosome 2, determines 
whether eumelanin (black melanin) or phaeomelanin (yellow 
melanin) is produced by hair follicular melanocytes. The 
melanocytes of wild type mice at this locus first produce 
eumelanin, followed by phaeomelanin and then again eumelanin. 
Due to this sequential production of eumelanin and 
phaeomelanin (Galbraith, 1964; Sakurai et al. 1975), the hair 
of these animals is characterized by a yellow and black band 
pattern. The melanocytes of non-agouti animals produce only 
eumelanin and as a result, their hair is uniformly black. 
Although it is known that sulphydryl compounds such as 
cysteine are elevated during phaeomelanin synthesis in agouti 
mice, the precise switch-mechanism which determines whether 
phaeomelanin or eumelanin is produced remains to be 
elucidated. 
Understanding how these two types of melanin are produced is 
further complicated by the fact that, in addition to the A 
locus, it is also dependent on the E locus (situated on 
chromosome 8). Previous studies have shown that while 
alleles at the A locus exert their effects by modifying the 
local tissue environment outside the melanocyte (Silvers & 
Russell, 1955; Silver, 1979), those at E locus act within 
melanocytes (Lamoreux & Mayer, 1975). 
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The brown or~ locus (situated on chromosome 4) also affects 
the production of melanin. The pMT4 cDNA (Shibahara et al., 
1986) mentioned earlier in this review, maps to this locus. 
Evidence to date (as revealed by electron microscopy) 
indicates that this locus is involved in determining the 
shape of melanosomes. In homozygous black mice (non agouti), 
eumelanin is synthesized on ellipsoidal melanosomes, whereas 
in homozygous brown mice, eumelanin is formed in smaller 
rounded melanosomes. 
It is clear from this discussion that various genetic loci 
interact to direct the synthesis and type of melanin produced 
in the melanocytes of wild type and mutant mice. 
1.6 TYROSINASE GLYCOSYLATION AND ITS ACTIVITY 
Tyrosinase is a glycoprotein with at least four to six 
potential glycosylation sites (Okhura et al., 1984; Hearing & 
Jimenez, 1987; Kwon et al., 1988; Hoganson et al., 1989; Kwon 
et al., 1989). Its ultimate structure is affected by the 
nature and extent of glycosylation. Glycosyltransferases 
(enzymes which add specific sugar residues to the protein 
core) add neutral sugar residues such as mannose, 
N-acetylglucosamine, galactose and fucose and terminal 
charged sialic sugar residues to the non-glycosylated 
tyrosinase isozyme, T3 , to form T1 and T2 isozymes (Hear
ing 
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et al., 1978, 1981; Imokawa & Mishima, 1982; Laskin & 
Piccini, 1986; Hearing & Jimenez, 1987). Previous studies 
have shown that the digestion of T1 tyrosinase isozyrne with 
neuraminidase (which cleaves off terminal sialic acid 
residues) results in T3 , the de novo form of tyrosinase 
Imokawa & Mishima, 1986). In contrast, Hearing et al. (1978, 
1981) demonstrated that the treatment of T1 with 
neuraminidase does not result in the T3 native form of 
tyrosinase. The results of the latter studies seem 
reasonable since the sugar composition of the T1 isozyrne 
includes residues such as mannose, galactose and sialic acid. 
Therefore, the conversion of T1 to T3 should result from the 
combined activity of a-mannosidase, ~-galactosidase and 
neuraminidase. The fully glycosylated form of tyrosinase, 
T1 , is packaged into coated vesicles and finally delivered to 
melanosomes, where it complexes with membrane components to 
form a high molecular weight complex T4 (> 250 000 Da) 
(Hearing, 1987). 
Glycosylation has been shown to affect the half-life of 
various .glycoproteins by rendering them resistant to 
proteolysis (Older et al., 1978) and by facilitation of 
proper folding (Paulson, 1989). The use of drugs such as 
tunicamycin or glucosamine (inhibitors of the synthesis of 
N-linked core glycosylation) has been shown to result in the 
aggregation of most glycoproteins in the endoplasmic 
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reticulum (Kornfeld & Kornfeld, 1985; Rademacher et al., 
1988). These results demonstrate the role of N-linked core 
glycosylation in intra-cellular translocation of 
glycoproteins. The inhibition of the synthesis of tyrosinase 
N-linked sugars by these drugs has already been tested in 
cultured B16 mouse melanoma cells. As expected, the 
treatment of these cells with either glucosamine (1 mg/ml) or 
tunicamycin (0.4 µg/ml) resulted in marked loss of pigment 
inside the melanosome as visualized by electron microscopy 
(Imokawa & Mishima, 1982). The depigmentation in these 
melanoma cells caused a 80-86% reduction in the incorporation 
of [ 3HJ-mannose after 5 to 10 hours of glucosamine treatment. 
Electrophoresis of tyrosinase under these conditions showed 
an increase in the T3 isozyme accompanied by a substantial 
decrease in the T1 form of the enzyme. Tyrosinase activity 
in the melanosomal fraction of glucosamine-treated melanoma 
cells was found to be significantly lower than that of the 
control. These results demonstrate that the loss of pigment 
in the melanosomes is d~e to the lack tyrosinase activity 
caused by the inhibition of the translocation of the enzyme. 
The inhibition of tyrosinase transportation to the 
melanosomes (similar to that induced by glucosamine or 
tunicamycin in vitro) has recently been identified by Imokawa 
et al. (1988) in the chinchilla mouse (genotype a/a, cch;cch, 
stain PW). In this study, it was shown using organ culture 
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and electron microscopy that the level of tyrosinase activity 
in Golgi-associated endoplasmic reticulum of lysosome (GERL) 
and coated vesicles was within normal range, but no activity 
was detected in melanosomes. The electrophoretic pattern of 
tyrosinase determined by SOS-PAGE showed the levels of the T1 
isozyme in chinchilla melanocytes to be much lower than that 
of the wild type black mouse (C57BL/6J strain). However, the 
supplementation of the culture medium with either 2 mM 
theophylline or dbc-AMP, resulted in markedly increased 
melanin deposition in the melanosomes as revealed by electron 
microscopy, suggesting the promotion of tyrosinase 
translocation by these agents. In contrast, it was found 
that the presence of a-MSH (1 mg/ml) in the culture medium 
did not result in increased melanin deposition in the 
melanosomes of this mutant. Although theophylline and dbc-
AMP were effective promoters of melanogenesis in chinchilla 
melanosomes, their mechanism of action is not known. One 
cannot assume that these agents act through their 
conventional c-AMP mechanism of action since in RPMI melanoma 
cells the stimulation of melanin formation by theophylline 
does not involve this pathway (Steinberg & Whittaker, 1976). 
In addition, a-MSH, which is known to act via this pathway, 
did not enhance melanosomal melanin formation in this mutant. 
The important conclusion from this study is that in vitro 
agents such as theophylline and dbc-AMP can override and 
correct for the genetic defect in the chinchilla mouse. 
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Following the description of the functional role of core 
glycosylation on tyrosinase, the discussion below will be 
restricted to the significance of terminal sugars on the 
activity of this enzyme. In general, terminal sugars are 
known to significantly alter the charge of glycoproteins, 
thereby affecting their solubility and conformational 
properties (Berman & Lansky, 1985). In a recent study, a 50-
to 100-fold variation in sialyltransferase mRNA levels were 
measured in different rat tissues, which were shown to 
correlate with the levels of enzyme activity (Paulson et al., 
1989). The role of sialic acid residues on tyrosinase 
activity has been demonstrated by using neuraminidase, which 
hydrolyzes the bonds joining the terminal sialic acid with 
internal sugar residues. The treatment of T1 tyrosinase 
isozyme purified from B16 melanoma cells resulted in a change 
in the pI from 3.3 to 4.2 as well as a 21% reduction in the 
activity of this enzyme (Hearing et al., 1981). 
Retinoic acid (RA), a vitamin A derivative, is an agent with 
diverse biological functions including cell differentiation 
(Yaar et al., 1981), cancer prevention in experimental 
animals (Moon et al., 1983) and pattern formation in 
developing limbs (Summerbell, 1983). In pigment cells, 
retinoic acid has been shown to promote melanogenesis in Hs 
939 human and S91 mouse melanoma cells (Lotan et al., 1978, 
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1981; Lotan, 1979; Lotan & Lotan, 1980). A dose-dependent 
increase in melanization caused by retinoic acid (10-lO M to 
10-6 M} was shown to result from a corresponding increase in 
tyrosinase activity in these cells. What needs to be 
elucidated is the mechanism by which retinoic acid promotes 
melanogenesis. Available evidence so far indicates that 
retinoic acid-stimulated tyrosinase activity in melanoma 
cells is accompanied by increased activity of 
sialyltransferases (Deutsch & Lotan, 1983; De Luca, 1977; 
Lotan et al., 1984). These results suggested that retinoic 
acid activates tyrosinase by facilitating the attachment of 
terminal sialic acid sugar residues. Recently, tyrosinase 
and cell surface glycoproteins have been shown to share the 
same intra-cellular glycosylation machinery (Imokawa & 
Mishima, 1988) (see Fig. 1.3). It is therefore likely that 
retinoic acid-stimulated activity of sialyltransferases may 
not only affect tyrosinase, but other cell surface 
glycoproteins. Since these cell surface glycoproteins are 
known to be mainly involved in metastasis of malignant cells 
(Hart et al. (1989), the elucidation of the role of 
glycosylation on tyrosinase activity may lead to a better 
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Fig. 1.3: Scheme showing the glycosylation pathway shared by 
tyrosinase and cell surface glycoproteins (After Imokawa & 
Mishima, 1988). pms, pre-melanosomes. 
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1.7 REGULATION OF MELANOGENESIS BY MSH 
1.7.1 Effect of MSH on tyrosinase activity and its signal 
transduction pathway. 
Melanocyte stimulating hormone (a-MSH), Ac-Ser-Tyr-Ser-Met-
Glu-His-Phe-Arg-Try-Gly-Lys-Pro-Val-NH2, which is synthesized 
in the pituitary gland, modulates integumental pigmentation 
of many vertebrate species. The two forms of this peptide 
hormone (a- and P-MSH) are derived from a 31 kd precursor 
hormone called pro-opiocortin (Fig. 1.4). Within this large 
pro-opiocortin fragment are the sequences of the 39 and 91 
amino acid residues of adrenotropic hormone (ACTH) and 
r-lipotropin respectively, which result from the specific 
proteolysis of this prohormone. ACTH is further cleaved 
after the 13th amino acid residue to yield a-MSH and a CLIP 
peptide consisting of amino acid residues 18-39 of the 
original ACTH molecule. Soon after the discovery of a-MSH, 
another form of this peptide, P-MSH, was isolated from the 
pituitaries of various mammalian species including humans. 
P-MSH, which is cleaved from P-lipotropin, comprises amino 
acid residues 41-58 of this fragment. Human pituitaries have 
been shown to lack a-MSH but to contain P-MSH which is longer 
(22 amino acids) than the P-MSH's (18 amino acids) from other 
mammalian pituitaries. It is interesting to note that a- and 
P-MSH, which are derived from different fragments, have 
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Fig. 1.4: Schematic representation of the known biologically 
active peptides derived from pro-opiomelanocortin which is 
found in the vertebrate pituitary (modified from Mac E. 
Hadley, 1989). Note the sequence homology between ~-MSH 
(amino acids 7-13) and a-MSH (amino acids 4-10). ACTH, 
adrenocorticotropic hormone, LPH, lipotropin, MSH, melanocyte 
stimulating hormone. 
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identical effects on skin pigmentation (Pomerantz & Chiang, 
1970; Seerchurn et al., 1988). Although the evolutionary 
significance of these two forms of MSH is not clear, their 
identical effects may be due the fact that they both contain 
the sequence, Met-Glu-His-Phe-Arg-Try-Gly, which has been 
shown to be the minimal amino acid sequence necessary for the 
unique biological activity of MSH (Abdel-Malek et al., 1985) 
(see also Fig 1.4). 
In general, MSH is known to be involved in the control of 
central body temperature (Samson et al., 1981; Murphy & 
Lipton, 1982), facilitation of selective learning functions 
(Handelman et al., 1983), camouflage of lower vertebrates 
such as amphibians (Kaestin et al. 1976; Fukuzuwa & Bagnara, 
1989) and mammalian seasonal color change (Rust, 1965). With 
respect to tyrosinase, a-MSH has been shown to increase the 
activity of this enzyme in various mammalian melanocytes 
including humans (Lerner & Mc Guire, 1964; Kitano, 1976) mice 
(Geschwind, 1966; Pomerantz & Chuang, 1970; Burchill et al., 
1986; Seerchurn et al., 1988), hamsters (Weatherhead & Logan, 
1981), and guinea pigs (Snell, 1964). What many pigment 
biologists have attempted to elucidate is the mechanism by 
which MSH increases tyrosinase activity in pigment cells. To 
date, several conflicting views on this subject have been 
reported. 
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A number of peptide hormones such as thyroid stimulating 
hormone (TSH), leutinising hormone (LH) and follicle 
stimulating hormone (FSH) are known to bind to specific 
receptor sites of the target cells and stimulate the activity 
of adenylate cyclase (a transmembrane enzyme), thereby 
instigating the formation of cyclic-3',5'-adenosine 
monophosphate (c-AMP) (De Robertis & De Robertis, 1987) (see 
Fig. 1.5). Like these hormones, a-MSH has been shown to 
promote melanogenesis in melanoma cells by increasing the 
levels of intra-cellular c-AMP (Bitensky et al., 1972; Wong & 
Pawelek, 1973; Varga et al., 1974; Wong & Pawelek, 1977; 
Fuller & Viskochil, 1979; Abdel-Malek et al., 1985; Satya et 
al., 1987; Abdel-Malek et al., 1987). The view that MSH acts 
through a c-AMP dependent mechanism, has been reinforced by 
the fact that known stimulators of the c-AMP pathway such as 
dibutyryl c-AMP, theophylline and isobutylmethylxanthine 
(IBMX) mimic the melanogenic effect of this peptide hormone 
(Hirobe & Takeuchi, 1977; Kwon et al., 1988). 
However, the role of c-AMP as an intra-cellular messenger 
which mediates melanogenesis has been challenged by a few 
recent studies (Hill et al. 1989; Abdel-Malek et al., 1989). 
In one these studies, Hill et al. (1989) used FlO, B16 Fl and 
B16 1° melanoma cell lines to study the mechanism of MSH 
action. These melanoma cells were cultured for 5 days in the 
presence of MSH (10-6 M to 10-
9 M) which increased the intra-
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Fig. 1.5: Scheme showing the activation of adenylate cyclase 
by hormones (first messengers) and the production of intra-
cellular c-AMP (second messenger) (After De Robertis and De 
Robertis, 1987). R, regulatory protein which binds GTP 
(Guanosine triphosphate). Note the activation of protein 
kinase by c-AMP. This enzyme has a catalytic (C) and a 
regulatory (R) subunit which forms an inactive complex. The 
free subunit is an active form, which phosphorylates proteins 
in the reaction. 
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cellular levels of c-AMP in all the three cell lines. 
Despite this increase in the levels of c-AMP, tyrosinase 
activity and melanin content were only elevated in B16 Fl and 
FlO cell lines, but not in the B16 1° cells. The mutation in 
these B 16 1· melanoma cells did not result in the absence of 
MSH receptors or a defective adenylate cyclase system, since 
c-AMP levels increased. Because of these results, they next 
explored the possibility that endogenous inhibitors caused 
the failure of MSH to increase tyrosinase activity in these 
cells. Tyrosinase activity measured in the mixture of B16 Fl 
and B16 1 ° cell lysates showed that the addition of lysate 
prepared from the latter cell line did not reduce tyrosinase 
activity in B16 Fl cells, suggesting the absence of 
inhibitors. Subsequently, the effect of calmodulin 
antagonists, N-(6-amino hexyl)-5-chloro-naphthalene-2-
sulphonamide and 5-iodo-c8-(N-[6-aminoacyl)-5-iodo-
naphthalene-1-sulphonamide}, on B16 1° melanoma tyrosinase 
activity was investigated. These antagonists of calmodulin 
(a calcium-binding protein which modulates the activity of 
many enzymes by transmitting the message carried through 
increased intracellular levels of calcium} caused an increase 
of tyrosinase activity in these mutant B16 1° melanoma cells. 
The precise role of the calmodulin pathway on melanogenesis 
is not known, however, these results showed that the 
inhibition of this pathway promoted melanogenesis. 
Calmodulin and calcium may act to inhibit tyrosinase activity 
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and the stimulatory effects of these calmodulin antagonists 
could be due to the release of this inhibition. These 
results are important because they show that in addition to 
c-AMP, calcium could also be involved in regulating 
melanogenesis. 
In a separate study, further evidence that MSH may not act 
via c-AMP has been put forward (Abdel-Malek et al., 1989). 
In this work, 2',5'-Dideoxyadenosine (DOA), a potent 
inhibitor of adenylate cyclase, was used to investigate the 
role of the c-AMP-dependent mechanism in MSH-mediated 
activation of tyrosinase. Cloudman S91 melanoma cells were 
cultured for 48 hours in media with or without ODA and 
supplemented with either a-MSH (10-7 M) or 10 µg/ml 
Postglandins E1 and E2 (PGE). DOA effectively inhibited a-
MSH- and PGE-stimulated increase of c-AMP formation, but 
resulted in the synergistic increase in tyrosinase activity. 
Subsequently, it was demonstrated that the treatment of these 
melanoma cells with either a-MSH or PGE in the presence of 
ODA, resulted in the recruitment of more cells to the G2 
phase of the cell cycle than in control culture media. 
Electron microscopy revealed more fully melanized melanosomes 
in those cells recruited to the G2 phase by a-MSH when 
compared to untreated cells. These findings also undermine 
the role of c-AMP-dependent mechanism in mediating 
melanogenesis and suggest that MSH may act via cell cycle-
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dependent mechanism. Thus, these recent findings which have 
shown that MSH may act via the calmodulin pathway or the cell 
cycle are important because they suggest multiple pathways 
for the control of melanogenesis by MSH and further show that 
the classic c-AMP pathway may not necessarily be the only 
transduction mechanism that MSH utilizes. 
1.7.2 Does MSH acts at a pre- or post-translational level? 
The question of whether MSH acts at a pre- or post-
translational level remains to be elucidated. Reports from 
various laboratories on this subject have so far been 
conflicting. Some studies suggest that MSH-stimulated 
tyrosinase activity is due to de novo synthesis of the enzyme 
(Hirobe & Takeuchi, 1977; Fuller & Viskochil, 1979; Fuller et 
al., 1987; Jimenez et al., 1988; and Kwon et al., 1988), 
while other reports suggest that MSH and activators of the 
c-AMP system enhance enzyme activity through post-
translational events (Lee et al., 1972; Wong & Pawelek, 1975; 
Korner & Pawelek, 1977). In this review, studies on the 
post-translational as well as the pre-translational 
regulation of tyrosinase activity will be described in depth 
beginning with the former control mechanism. 
Wong & Pawelek (1975) used synchronized cell cultures of 
Cloudman S91 melanoma to investigate the effect of MSH on 
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tyrosinase activity in the presence of cycloheximide (a 
protein synthesis inhibitor) or actinomycin D (RNA synthesis 
inhibitor). Results showed that even in the presence of 
either cycloheximide or actinomycin D, MSH increased 
tyrosinase activity 15- to 30-fold compared to untreated 
cells. From these results, it was not clear whether this 
increase in tyrosinase activity in the presence of MSH was 
due to the direct activation of the enzyme or? decrease in 
the degradation rate of the enzyme. To investigate the 
latter possibility, melanoma cells were cultured for 48 hours 
in DMEM with or without MSH. After this period of culture, 
protein synthesis was blocked and tyrosinase activity 
measured at different intervals. No significant difference 
I 
in tyrosinase activity was found between MSH-treated and 
untreated cells, suggesting that the hormone did not alter 
the degradation rate of tyrosinase. In addition, melanoma 
cells were cultured for 48 hours in [ 3HJ-leucine-supplemented 
DMEM with or without MSH. Since the levels of [ 3HJ-leucine 
incorporation in MSH-treated cells was the same as in control 
cultures, this suggested that MSH did not promote the 
synthesis of new enzyme molecules. On the basis of these 
results, the main conclusion proposed in this study was that 
the increase in tyrosinase activity in the presence of MSH 
was due to the activation of pre-existing enzyme. 
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In a later study, Korner & Pawelek (1977) investigated the 
effect and mechanism of MSH action in PST-HGPRT-1 melanoma 
cells (a cell line with low basal tyrosinase activity). The 
relationship between MSH, c-AMP-dependent protein kinase and 
tyrosinase activity was investigated. A 30 OOOg supernatant 
fraction was prepared from these melanoma cells and incubated 
with c-AMP-dependent protein kinase. It was found that 
tyrosinase activity markedly increased in response to this 
protein kinase. However, when the 30 OOOg supernatant was 
prepared from cells that were pre-exposed to MSH in culture, 
the addition of c-AMP dependent protein kinase did not result 
in a further activation of tyrosinase. These results 
suggested that the mechanism of action of MSH and c-AMP-
dependent protein kinase in activating tyrosinase could be 
similar. 
In subsequent experiments aimed at understanding the 
mechanism by which c-AMP dependent protein kinase could 
activate tyrosinase, an unidentified protein kinase modulator 
(an inhibitor of c-AMP dependent protein kinase) was used. 
As expected, it was found that the presence of protein kinase 
modulator in the 30 OOOg fraction inhibited both the protein 
kinase and the activation of tyrosinase, but it had no effect 
on the enzyme that was activated already. Later, the 30 ooog 
fraction was shown to contain an inhibitor of tyrosinase 
which disappeared on the addition of c-AMP dependent protein 
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kinase. The suppression by the kinase of this inhibition 
correlated with the disappearance of acid-precipitable 
[ 32PJ-counts. This decay of acid-precipitable [
32 PJ-counts 
did not result from proteolytic degradation since [
3HJ-
leucine-labelled proteins added to the same assay system were 
not degraded. These results clearly indicated that the 
disappearance of [ 32 PJ-counts was due to the inactivation of 
an inhibitor. 
In summary, the major findings of this study were that 
(a) c-AMP-dependent protein kinase mediated the inactivation 
of a tyrosinase inhibitor through phosphorylation events and 
(b) since the kinase failed to further activate tyrosinase in 
cells pre-treated with MSH, it was assumed that the effect of 
MSH was also to remove this inhibitor. On the basis of these 
results, a model was proposed that MSH mediated the post-
translational activation of tyrosinase by phosphorylating a 
tyrosinase inhibitor in order to release this inhibitor. 
In contrast to the previous results indicating that MSH acts 
at a post-translational level, Fuller & Viskochil (1979) 
showed that both RNA and protein synthesis mediate the short-
term activation of tyrosinase by MSH. In this study, the 
increase in tyrosinase activity in S91 melanoma cells 
occurred 6-9 hours after MSH administration. One of the 
questions that needed to be answered was: What happened 
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during this 9-hour period which these investigators called 
' the silent period'? Subsequent results showed that within 
this lag period, there was first a transient increase in 
intra-cellular levels of c-AMP within 20 minutes, followed by 
an increase in RNA and protein synthesis 4-6 hours before the 
increase of tyrosinase activity. To gain further insight 
into the role of transcription and translation on MSH-
mediated tyrosinase activation, the effects of cycloheximide 
(0.28 µg/ml) and actinomycin D (0.05 µg/ml) were tested on 
tyrosinase activity stimulated by MSH (10-
7 M). The addition 
of either cycloheximide or actinomycin Din the culture media 
resulted in the 3- to 4- fold decrease in tyrosinase 
activity. These results demonstrated that protein and RNA 
synthesis were an absolute requirement for the short-term 
activation of tyrosinase by MSH (i.e. over a period of 24 
hours). Furthermore, to confirm the level of MSH action, a 
double labelling technique was used. Melanoma cells were 
first cultured for 4 days in media containing [
3HJ-leucine 
and [ 14cJ-tyrosine, then in the presence of MSH for an 
additional 30 hour period. It was confirmed that MSH 
increased tyrosinase activity by promoting the de novo 
synthesis of the enzyme, since the ratio of [
14cJ-tyrosine to 
[ 3HJ-leucine in MSH treated cells was found to be two fold 
higher than in untreated cells. 
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In a similar study, Fuller & Visckochil (1987) extended their 
investigation by studying the effect of a-amanitin (an RNA 
polymerase II inhibitor) and cordycepin (an inhibitor of 
polyadenylation) on tyrosinase activity in Cloudman S91 
melanoma cells. Both a-amanitin (10 µg/ml) and cordycepin 
{l µg/ml) effectively suppressed a-MSH-stimulated tyrosinase 
activity. The results of this study also showed that MSH-
mediated increase in tyrosinase activity was due to increased 
transcriptional rate of the enzyme in melanoma cells. 
In an attempt to resolve the controversy about the level of 
MSH action, Halaban et al. {1984) investigated the effect of 
this hormone, dibutyryl c-AMP and isobutylmethylxanthine 
(IBMX) on tyrosinase activity in S91 melanoma cells. The 
relationship between the changes in tyrosinase activity and 
its abundance in response to MSH was investigated. Results 
demonstrated that MSH, IBMX and dibutyryl c-AMP caused an 
increase in tyrosinase activity that was directly 
proportional to the abundance of the enzyme. In fact, it was 
found that MSH stimulated a four fold increase in the 
activity as well as in the synthesis of tyrosinase. In 
addition, the model proposed by Korner & Pawelek {1977), 
(i.e. that MSH mediated the phosphorylation and the 
inactivation of a tyrosinase inhibitor) was also re-
investigated in this work. Melanoma cells, cultured in the 
presence and absence of MSH, were incubated with 
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[32Phosphorus]. Analysis of immunoprecipitated tyrosinase
 
from MSH-treated melanoma cells showed no (
32 Phosphorus] 
incorporation. These results do not disprove the hypothe
sis 
of Korner and Pawelek (1977) since they proposed that it 
is 
the tyrosinase inhibitor that is phosphorylated, not the 
enzyme itself. In addition, Fuller & Visckochil {1987) also 
found that c-AMP-dependent protein kinase had no effect on
 
tyrosinase activity in melanoma cells. Although the work 
done by these investigators (Halaban and co-workers; Full
er & 
Viskochil), did not confirm the model proposed by Wong & 
Pawelek {1977), they did not propose an alternative model 
of 
MSH action. 
Due to the recent success in the cloning and sequencing o
f 
tyrosinase cDNA's from human (Kwon et al., 1987) and mous
e 
(Yamamoto et al., 1986; Kwon et al., 1988; Muller et al., 
1988; Hoganson et al., 1989), the changes in the levels o
f 
mRNA in melanocytes and various melanoma cell lines in 
response to MSH can now be directly quantitated by means o
f 
these probes. Kwon et al. {1988) used a tyrosinase cDNA t
o 
determine the levels of mRNA in S91 Cloudman melanoma cel
ls 
treated with fi-MSH or IBMX or fi-MSH plus IBMX. Melanoma 
cells were cultured for 4 days in the presence and absence
 of 
fi-MSH (0.2 µM) or IBMX (0.02 mM) or both agents. The prese
nce 
of either fi-MSH or IBMX increased tyrosinase activity six
-
fold above control. When fi-MSH was added together with IB
MX, 
34 
tyrosinase activity increased 20 times above control. 
Northern blot analysis revealed that this increase in 
tyrosinase activity stimulated by either P-MSH or IBMX was 
accompanied by a proportional increase in the levels of 
tyrosinase mRNA. The quantity of mRNA in cells treated with 
both p-MSH and IBMX was six-fold higher than those treated 
with either P-MSH or IBMX. These results demonstrate that 
the increase in the expression of tyrosinase activity is due 
to an increased rate of transcription as shown by levels of 
mRNA and confirm previous reports on this subject (Fuller & 
Viskochil, 1979; Halaban et al., 1984; Fuller et al., 1987). 
In support of the above results reported by Kwon et al. 
(1988), another mouse cDNA has been used to explore the 
transcriptional regulation of tyrosinase activity in 
amelanotic (AM-7AS) and melanotic (MEL-llAS} melanoma cell 
lines (Hoganson et al., 1989). Treatment of the amelanotic 
and melanotic cell lines with MSH resulted in a 2- and 3.7-
fold increase in tyrosinase mRNA respectively. These results 
together with those of Kwon et al. (1988) clearly demonstrate 
that the activation of tyrosinase by MSH involves the 
synthesis of tyrosinase mRNA transcripts and therefore show a 
transcriptional control of tyrosinase activity by the 
hormone. 
35 
1.8 THE EFFECT OF TEMPERATURE ON TYROSINASE ACTIVITY 
Temperature is known to affect the kinetics of most enzyme-
catalyzed reactions and tyrosinase is no exception. A study 
by Chen (1975) provided useful information regarding the 
effect of temperature on tyrosinase activity in a variety of 
vertebrates ranging from amphibians to mammals and in 
melanoma cells. Tyrosinase activity was measured in crude 
homogenates of skins and melanoma cells by means of a 
radiometric assay which measures [ 14cJ-tyrosine incorporation 
into melanin. He showed that maximal tyrosinase activity in 
most vertebrates and in melanoma cells occurred between 35°C 
and 45°C. It was further shown that the lowering of skin 
temperature reduced tyrosinase activity, suggesting that 
optimal activity of mammalian tyrosinase occurred at normal 
body temperature. 
In contrast, maximal synthesis of melanin in mutant mammals 
such as the Himalayan rabbit (Chaudhuri, 1929) and Himalayan 
mouse (Green, 1961) occurs below the normal body temperature. 
Further histological examination of Himalayan hair follicles 
also confirmed that there is more melanin deposition below 
body temperatures than at 37°C (Kidson & Fabian, 1979). At 
this stage, it was not clear whether this was due to the 
direct increase in tyrosinase activity or post-tyrosinase 
factors. In order to resolve this issue, Himalayan 
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tyrosinase activity was measured in a crude homogenate at 
various temperatures between l6°C and 60 °C and compared to 
that of the wild type brown mouse (Kidson & Fabian, 1981). 
By using the [ 14cJ-tyrosine and [ 3HJ-tyrosine assays 
described by Hearing and Ekel (1976) and Pomerantz (1964) 
respectively, it was shown that maximal melanin deposition 
occurring below 37°C, corresponded with maximal tyrosinase 
activity at± 25° c. 
The next question addressed in the above study was whether 
the inactivation of the Himalayan enzyme at 37° C was due to 
endogenous tyrosinase inhibitors. By running a crude 
homogenate prepared from the Himalayan skin on a Sephadex G-
25 column, it was shown that at 37°C, the removal of a low 
molecular weight fraction from the homogenate resulted in a 
27% to 96% increase in tyrosinase activity. The addition of 
this low molecular weight fraction to the original homogenate 
from which it was isolated, resulted in a 6% to 34% decrease 
in tyrosinase activity. However, when the mixture was 
assayed at 25°C, there was no reduction in tyrosinase 
activity. These results suggested the presence of a 
tyrosinase inhibitor in the Himalayan skin that was tightly 
bound to the enzyme at normal body temperature. 
While Himalayan tyrosinase activity had been measured in a 
crude homogenate by Kidson and Fabian (1981), it was 
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impossible then to carry out this investigation in isolated 
melanocytes due to the inability, at that stage, to establish 
pure melanocyte cultures in vitro. Recently, a technique 
developed by Tamura et al (1987) alleviated this problem. 
Using this technique, Halaban et al. (1988) cultured a 
variety of mouse melanocytes including those of normal wild 
type (BlO.BR-C/C & C57BL/6J-C/C) and Himalayan (ch/ch) 
strains. In this study, the effect of temperature (30°C to 
45°C) and DOPA (0.1 µM to 1000 µM) on tyrosinase activity 
were investigated. In support of Kidson & Fabian (1981), it 
was also found that the Himalayan tyrosinase activity was 
higher at 30°C than at 37°C. Furthermore, the response of 
the Himalayan and B10.BR tyrosinase to various concentrations 
of DOPA at 30°C were similar, whereas at 37°C, 20 times less 
DOPA was required to maximally activate the Himalayan 
tyrosinase when compared to the BlO.BR enzyme, further 
confirming low levels of tyrosinase activity at 37°C. Most 
importantly, the reduction of the Himalayan tyrosinase 
activity at 37°C was found to be accompanied by a significant 
reduction in the ability of this mutant to incorporate 
radioactive mannose and N-acetylglucosamine than in the wild 
type. In addition, the molecular weight of the 
immunoprecipitated Himalayan tyrosinase corresponded to the 
underglycosylated enzyme. Since carbohydrate residues are 
known to regulate the stability, turnover and the proteolytic 
resistance of glycoproteins, it was proposed that the lower 
Himalayan tyrosinase activity at 37°C resulted from an 
unstable enzyme that was susceptible to proteolytic 
degradation. 
1.9 OUTLINE AND AIM OF INVESTIGATION 
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It is clear from the evidence presented in this review that 
some of the key factors that determine the activity of 
tyrosinase are; glycosylation, MSH and environmental 
temperature. Very little is known about how these factors 
interact in activating tyrosinase and their mechanisms of 
action are still poorly understood. In particular, it is not 
known precisely whether the short-term regulation of 
tyrosinase activity by these agents is controlled at the 
level of transcription or post-transcription. 
The present study has used wild type and mutant mice at the~ 
locus and transformed melanocytes to investigate the control 
of melanin synthesis in pigment cells. The mice used are; 
the normal wild type (C57BL/6J-C/C) (which optimally 
synthesizes melanin at normal mammalian body temperature), 
the Himalayan (C57BL6J-ch;ch) mutant (which optimally 
synthesizes melanin at temperatures below normal mammalian 
body temperatures) and albino (Balb C-c/c) mutant (which does 
not synthesize melanin). The Himalayan mouse is particularly 
interesting because of conflicting reports with regard to 
identification of the actual mutation. 
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As a preliminary step in resolving these issues, the 
temperature sensitivity of the Himalayan melanocytes was 
confirmed by housing these mice under different temperature 
conditions and visually observing the resulting color of the 
hair (see Fig. 1.6). In chapter 2, an attempt was made to 
investigate the general mechanism of a-MSH action by studying 
the effect of this hormone on wild type, Himalayan and albino 
tyrosinase activity and to determine whether a-MSH acts at a 
pre- or post-translational level. In chapter 3, the 
possibility that the Himalayan tyrosinase could be 
underglycosylated compared 
to the wild type enzyme was investigated. Finally, the role 
of translation and transcription as additional control 
mechanisms of tyrosinase activity was explored (Chapter 4). 
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Fig. 1.6: The coat color of Himalayan mice housed under 
different temperature environments. H1 , mouse housed under 
cold temperature conditions (15°C); H2 , mouse housed at room 
temperature (22°C). Note that the Himalayan moused at 15°C 
appears darker than that at 22°C 
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CHAPTER II 
EFFECT OF a-MSH ON TYROSINASE ACTIVITY IN CULTURED SKIN 
EXPLANTS 
2.1 INTRODUCTION 
Melanocyte stimulating hormone (MSH), synthesized and 
secreted by the pars intermedia of the pituitary gland, 
modulates integumental pigmentation of many vertebrates. 
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This neuropeptide has previously been shown to increase 
tyrosinase activity in mouse hair follicle melanocytes 
(Hirobe & Takeuchi, 1977; Weatherhead & Logan, 1981; Burchill 
& Thody, 1986; Burchill et al., 1988; Seerchin et al., 1988) 
and mouse melanoma cells (Wong & Pawelek, 1973, 1975; Pawelek 
1976; Hu et al., 1977; Korner & Pawelek, 1977; Fuller & 
Viskochil, 1979; Halaban et al., 1984; Abdel-Malek et al., 
1985,1986; Levine et al., 1987; Kwon et al., 1988; Hill et 
al., 1989). However, the question of whether the hormone 
acts at a pre- or post-translational level still remains to 
be elucidated. Reports on this subject have so far been 
conflicting; some studies suggest that MSH-stimulated 
tyrosinase activity is due to de novo synthesis of the enzyme 
(Hirobe & Takeuchi, 1977; Fuller & Viskochil, 1979; Fuller et 
al., 1987; Jimenez et al., 1988; and Kwon et al., 1988), 
while others suggest that MSH and activators of the c-AMP 
system enhance enzyme activity through post-translational 
events (Wong & Pawelek, 1973; Wong et al., 1974; Wong & 
Pawelek, 1975; Korner & Pawelek, 1977). This subject has 
been reviewed in detail in the General introduction. 
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The primary aim of this study was to investigate the effect 
of MSH on tyrosinase activity of the following mice; normal 
wild type (C/C) (which maximally synthesizes melanin at 
normal body temperature), Himalayan (ch;ch) (a mutant which 
maximally synthesize melanin at temperatures<< 37°C) and 
albino (a mutant which does not synthesize melanin). Earlier 
studies carried out on Himalayan tyrosinase showed that the 
reduced enzyme activity at 37°C is possibly due to a strong 
enzyme-inhibitor affinity (Kidson and Fabian, 1981). On the 
other hand, more recent evidence indicates that the 
temperature-sensitivity of the Himalayan tyrosinase is due 
the underglycosylation of this enzyme (Halaban et al., 1988). 
In addition, the analysis of the Himalayan cDNA has revealed 
that the mutation in this mouse is due to a change of a 
histidine to an arginine residue at the amino acid 420 (Kwon 
et al., 1989). The present study has investigated the 
mechanism of MSH action by studying the effect of the hormone 
on the Himalayan tyrosinase activity at a temperature that 
normally inhibits melanin synthesis (i.e. 37°C). If a-MSH 
does activate the Himalayan tyrosinase under these 
conditions, this would provide some clues about this mutant 
enzyme and the general MSH action. 
As a starting point, it was necessary to establish an assay 
that would make it possible to quantitate the levels of 
tyrosinase activity due to MSH action in vitro. Most studies 
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on MSH action have been carried out on cultured melanoma 
cells with one or two on whole skin. The latter studies were 
carried out by directly injecting MSH into the skins of 
living mice (Gershwind 1966; Gershwind et al., 1972), but 
this procedure has practical limitations because: 
(a) It is difficult to quantitate and control the amount of 
hormone injected and therefore impossible to measure the 
tissue levels of this hormone. 
(b) It is also not possible to quantitate the level of 
enzyme activity due to MSH action in vivo, so evaluation 
of injected hormone depends on the subjective visual 
observation of pigment formation. 
A number of radiometric assays have been shown to be 
sensitive enough to measure tyrosinase activity in vitro 
(Pomerantz, 1966; Hearing & Ekel, 1976). The main 
disadvantage with these assays is that they measure 
tyrosinase activity in a crude homogenate and therefore 
unsuitable for hormonal studies since hormones act by binding 
to cell surface receptors of target cells (Varga et al., 
1974; de Robertis & de Robertis, 1987). To overcome the 
problems of quantitation inherent with in vivo studies and a 
crude homogenate, the next viable option was to use cultured 
mouse skin melanocytes. In an attempt to isolate and culture 
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mouse skin melanocytes, a method recently developed by Tamura 
et al. (1987) was used. The major obstacle encountered with 
this technique was the lack of success of eliminating 
fibroblast contamination. Finally therefore, a radiometric 
assay developed by Gatsios and Kidson (1986) from that 
originally described by Kitano and Hu (1971) was used. This 
assay measures tyrosinase activity of skin explants cultured 
on glucose-agar medium in the presence of cycloheximide (a 
protein synthesis inhibitor). It was shown that the 
inhibition of protein synthesis by cycloheximide (0.9 µM) 
does not affect the levels of tyrosinase activity intended to 
be measured. Furthermore, this assay has two major 
advantages over other conventional assays used in studies 
involving melanoma cells because: 
(a) Concentrations of exogenous MSH can easily be varied and 
the effect of this hormone on tyrosinase activity can be 
measured by quantitating the incorporation of 
radioactive tyrosine into melanin during a-MSH 
treatment. 
(b) It preserves the normal histological condition of skin 
in vitro and therefore possibly provides a reasonable 
model for the events that occur in vivo. 
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The limitation of this assay technique is that skin removed 
from its natural environment is subject to gradual autolysis. 
A measure of this rate of autolysis can be estimated by 
studying its protein synthesis as function of time. By 
measuring [ 3HJ-leucine uptake over a 48 hour period, Gatsios 
and Kidson (1986) showed that skin can be cultured up to 24 
hours with minimal tissue deterioration. They also assessed 
the reliability of this assay by comparing [ 14cJ-tyrosine 
uptake in highly pigmented agouti and non-pigmented albino 
skins. Agouti tyrosinase activity was, as expected, found to 
be 85% to 90% higher than that of the albino mutant. Taken 
together, these factors show that this radiometric assay is 
the best ·tool' to use in studying the' effect of MSH in 
vitro. 
47 
2.2 MATERIALS AND METHODS 
2.2.1 Animals 
Himalayan mice (C57BL/6J-ch;ch) were obtained from the 
Jackson Laboratory, Bar Habour, USA; Black mice (C57BL/6J-
C/C) and albino mice (Balb c;J-c/c) were obtained from the 
Animal Unit, University of Cape Town. Four to five day old 
mice were used in all experiments unless otherwise stated. 
2.2.2 In vitro radiometric assay 
2.2.2.1 Enzyme preparation 
Mouse skins were homogenized using a Polytron ultra-
homogenizer in 0.1 M phosphate buffer (pH 7.4) containing 
0.1% Triton X-100. Phenyl-methyl sulfonyl-fluoride (a 
protease inhibitor) was added to a final concentration of 
10-4 M. The homogenate was centrifuged at 20 ooog for 20 
minutes and the resulting supernatant used to determine 
enzyme activity. Protein determination was carried out using 
biuret reaction according to Bradshaw (1966). 
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2.2.2.2 Measurement of tyrosinase activity 
This assay was carried out according to the method of Chen & 
Chavin (1965) as modified by Hearing & Ekel (1976). The 
assay specifically measures the incorporation of c14cJ-
tyrosine into acid insoluble melanin. Each assay was carried 
out in duplicate (final volume 25 µl) and contained 10 µl of 
skin homogenate in phosphate buffer, 5 µl of ( 14cJ-tyrosine 
(0.5 µCi/ml, specific activity 375 µCi/mmole) (ICN 
Radiochemicals), 5 µl of solution containing chloramphenicol 
(lmg/ml), cycloheximide (0.9 µM), penicillin G (1000 
units/ml) and 5 µl of 0.05 M dihydroxyphenylalanine (dopa). 
For the determination of non-enzymatic incorporation of 
( 14cJ-tyrosine, the homogenate was substituted with 0.1 M 
phosphate buffer (pH 7.4). 
After five hours of incubation in a water bath at 37°C, the 
mixture was micropipetted onto GFC Whatmann discs, washed 
twice with 10% trichloroacetic acid (TCA) for 5 minutes, then 
successively rinsed in 90% ethanol and acetone for 5 minutes 
and air-dried. Finally, the proteins were solubilized with 
0.1 ml Soluene (Packard) and counted in 5 mls of toluene 
scintillator (Packard) in a Packard Tricarb liquid 
scintillation counter. Tyrosinase activity was expressed as 
cpm/µg of protein of homogenate. 
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2.2.3 Skin culture radiometric assay 
2.2.3.l Preparation of skin explants 
Four to five day old mice were killed and immediately rinsed 
in 70% alcohol and in phosphate buffer saline (PBS) (0.5 M 
NaCl; 2.7 mM KCl; 3 mM KH2Po4 and 28 mM Na 2HP04 .12H20, pH 
7.4) in quick succession. Skin explants of approximately 
2 mm2 were cut from the dorsal area and subcutaneous fat 
removed. 
2.2.3.2 Measurement of tyrosinase activity in skin explants 
Skin explants were cultured with dermis facing down at 37°C 
for 18 hours on glucose albumin agar (GAA) medium containing 
cycloheximide (0.9 µM) and ( 14cJ-tyrosine (0.5 µCi/ml, 
specific activity 513 µCi/mmole) (Amersham) in a humidified 
chamber. GAA medium was prepared as follows: Thin albumin 
from an unfertilized chick egg was mixed in a 1:1 ratio with 
sterile glucose agar (2 g bacto-agar and 1 g dextrose) in 100 
mls of mammalian saline (0.18 M NaCl; 5mM KCl and 2.2 mM 
NaHco3 ; pH 7.4) in a water-bath maintained at 50°C. 
Included in the culture medium were 2.1 mg/ml penicillin G, 
4.3 mg/ml streptomycin-sulfate and 150 unit/ml mycostatin. 
50 
After culture, explants were washed in 0.4 M perchloric acid 
(PCA) for 18 - 24 hours, and rinsed twice in 0.2 M PCA for 10 
minutes, dehydrated in alcohol and ether in succession for an 
hour and dried in an oven at 37°C overnight. After drying, 
the tissues were weighed, placed in glass scintillation vials 
and solubilized in 200 µl Soluene (Packard). Radioactivity 
was counted in a Packard Tricarb liquid scintillation counter 
in 5 mls toluene scintillator (Packard). Tyrosinase activity 
was expressed as cpm/mg of dry tissue weight. 
2.2.4 Measurement of a-MSH-stimulated on tyrosinase 
activity in skin explants 
Wild type, albino and Himalayan mouse skin explants were 
prepared as described in paragraph 2.2.3.1. They were 
cultured for six hours on glucose agar albumin (GAA) medium 
containing a-MSH (Boehringer-Mannheim) at a concentration 
ranging from 10-9 M to 10-4 M (as specified in each 
experiment) then assayed for tyrosinase activity as 
previously described (paragraph 2.2.3.2.). In order to 
measure the effect of a-MSH when protein synthesis was 
blocked, cycloheximide (0.9 µM) was added during the culture 
period as well as during the assay period. 
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2.2.5 Culturing of normal murine melanocytes 
2.2.5.1 Preparation for melanocyte culture 
All glassware was autoclaved and dissecting instruments were 
sterilized with 70% alcohol. Human placental extract (HPE) 
was prepared as follows; whole placenta was first washed with 
sterile PBS and homogenized using a Polytron ultra-
homogenizer. The homogenate was centrifuged at 10 OOOg for 
20 minutes and the resulting supernatant was used as 
placental extract. Dulbecco's Minimal Essential Medium 
(DMEM) and HPE were sterilized using a 0.45 µm filter. HPE 
and foetal calf serum (FCS) were inactivated for 30 minutes 
in a water-bath maintained at 50°C. Mice were killed with 
chloroform, rinsed in 70% alcohol and sterile PBS and the 
skin was collected from the dorsal area and processed as 
described below. 
2.2.5.2 Isolation of melanocytes from skin 
Method 1 
Skins of 4-5 day old mice were treated with 0.25% trypsin and 
0.02% collagenase in phosphate buffer (0.1 M, pH 7.4) for 1 
hour at 37°C. The tubes containing the skins were vortexed 
after every 15 minutes so as encourage disaggregation of 
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cells. After digestion, released cells and tissue debris were 
spun down at 2 OOOg and resuspended in TIP medium (DMEM 
containing 48 nm 12-0-tetradecanoyl-phorbol-13-acetate (TPA); 
0.1 mM isobutylmethylxanthine (IBMX); human placental extract 
(50 µg protein/ml); penicillin G (200 units/ml, Sigma); 100 
µg/ml streptomycin) and plated onto tissue culture dishes. 
Cells were cultured in an incubator at 5% co2 and 70% 
humidity. Tissue debris were sucked out after 2 days of 
culture. 
Method 2 
The second method used for the isolation of skin melanocytes 
was modified from that developed by Tamura et al (1987). 
Newborn to 4 day old mouse skins from the dorsal area were 
incubated in 0.25% trypsin in DMEM at 37°C for 3 hours or at 
4°C overnight. The dermis was carefully separated from the 
epidermis by means of forceps and placed separately into TIP 
medium, teased apart with jeweler's forceps and transferred 
to 25 cm2 culture dishes, then suspended in a small volume of 
culture medium to facilitate optimal attachment of 
melanocytes. 
After 48 hours of culture, the debris were removed and fresh 
TIP medium was supplemented with Geneticin (100 µg/ml). 
After treatment with Geneticin for two days, melanocytes were 
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cultured in Geneticin-free TIP medium. Melanocytes were then 
cultured either at 30°C or 37°C at 70% humidity and 7% co2 . 
After 5 days in culture, the melanocytes were detached with 
0.05% EDTA-0.02% trypsin, homogenized in a 1 ml mini 
homogenizer and homogenate prepared according to the 
procedure in 2.2.2.1. Tyrosinase activity was measured by 
means of an in vitro radiometric assay (see paragraph 
2.2.2.2.). Mouse 3T3 cells were used as a source of 
tyrosinase-negative cells. 
2.2.6 Statistical Analysis 
The statistical significance of all results was determined by 
Student's t-test unless otherwise specified. Values of P ~ 
0.05 were considered as being insignificant. 
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2.3 RESULTS 
2.3.1 Tyrosinase activity in cultured skin explants 
The radiometric assay used in this study to measure 
tyrosinase activity in cultured skin explants has previously 
been tested and shown to be reliable as a quantitative 
measure of tyrosinase activity in vitro (Gatsios and Kidson, 
1986). Nevertheless, this method was put to the test by 
determining the incorporation of [ 14cJ-tyrosine into explants 
of black mouse skin cultured in the presence of 0.9 µM 
cycloheximide and 1 rnM phenylthiourea (a specific tyrosinase 
inhibitor). Approximately 92% of [ 14cJ-tyrosine 
incorporation was reduced in the presence of cycloheximide 
and a further 6% by phenylthiourea. The remaining 2% in the 
presence of both inhibitors was considered as background 
uptake of [ 14cJ-tyrosine uptake. These results showed that 
the inhibition of general protein synthesis by cycloheximide 
does not affect the incorporation of [ 14cJ-tyrosine due to 
melanin synthesis. Thus, the 6% reduction in [ 14cJ-tyrosine 
incorporation caused by phenylthiourea represents tyrosinase 
activity. 
The sensitivity of this skin culture radiometric assay was 
further put to test by using it to measure levels of 
tyrosinase activity in skin explants of Himalayan mice housed 
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at different temperature·s. Himalayan mice housed at 15°C and 
at room temperature (± 22 °C), albino and wild type skin 
explants were assayed for tyrosinase activity for 18 hours in 
the presence of [ 14cJ-tyrosine and cycloheximide (0.9 µM). 
This experiment was carried out twice and results are 
presented in Table 2.1. Since albino skins are known to have 
no tyrosinase activity, the ·incorporation into these tissues 
was considered as background. This background incorporation 
was subtracted from the activity measured in wild type and 
Himalayan skins. The incorporation of [ 14cJ-tyrosine into 
explants of Himalayan mice housed at 15°C was found to be 
31-47% higher than skins from those housed at room 
temperature. The incorporation of [ 14cJ-tyrosine in the wild 
type strain was 1.5 to 2.8 fold higher than that of the 
Himalayan mice housed at room temperature. 
2.3.2 In vitro radiometric assay 
Skins of Himalayan and wild type mice were used to prepare 
crude homogenates as described in paragraph 2.2.1.1 .. 
(homogenates were prepared from Himalayan mice housed at both 
15°C and 22°c). Tyrosinase activity was assayed for 5 hours 
in the presence of [ 14cJ-tyrosine. It was found that 
tyrosinase activity of Himalayan mice housed at 15°C was 
55-117% higher than those raised at room temperature (Table 
2.1). It is interesting to note that in the in vitro assay, 
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Table 2.1 
























± 1 013 
± 883 
± 1 069 
homogenate 
10 112 ± 644 
15 755 ± 801 
138 088 ± 2 781 
8 125 ± 941 
17 665 ± 571 
142 556 ± 4 064 
a Mouse skin explants were assayed for tyrosinase activity for 18 hour 
in the presence of ( 14cJ-tyrosine (0.5 µCi/ml) and cycloheximide (0.9 
µM) as described in materials and methods. Values represent means of 
three measurements± S.D. 
b Crude homogenate wa·s prepared from mouse skins as detailed in 
materials and meth~ds and tyrosinase activity assayed for 5 hours in 
the presence of [ 1 CJ-tyrosine. Ea~h data point represent an average 
of duplicate mta¥urements ± S.D. H .T, Himalayan mice housed at room 
temperature; H · , Himalayan mice housed at 15°C; W.T, wild type mouse 
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the tyrosinase activity of the wild type homogenate was 13-16 
times higher than the Himalayan skin, whereas in the skin 
culture assay wild type activity was 1.5 to 2.7 fold greater. 
The implications of these results is addressed in the 
discussion. 
2.3.3 Melanocyte culture 
Melanocytes were isolated from mouse skins, cultured in TIP 
medium and assayed in vitro for tyrosinase activity as 
detailed in materials and methods. Tyrosinase activity in 
Himalayan melanocytes cultured at 30°C for 5 days was 
approximately 45% higher than those cultured at 37°C (Fig. 
2.1). Tyrosinase activity in melanocytes cultured either at 
30°C or 37°C, was found to be significantly higher than the 
incorporation in 3T3 cells (P < 0.05). 
2.3.4 The effect of a-MSH on tyrosinase activity 
In order to determine the effect of a-MSH on tyrosinase 
activity, the skin culture radiometric assays was used. Wild 
type, Himalayan and albino skin explants were cultured for 
six hours in media containing various concentrations of MSH 
and then assayed for tyrosinase activity for 18 hours. This 
experiment was repeated at least three times with similar 

















3T3 Him(37'C ) Him(30'C) 
Fig. 2.1: Tyrosinase activity in cultured melanocytes. 
Himalayan melanocytes were isolated from newborn to 4 day old 
mouse skins, cultured at either 30°C or 37°C in TIP medium 
and assayed for tyrosinase activity (see materials and 
methods). Each value represents a mean of two measurements. 
All values are significantly different from control (3T3) (P 
< 0.05). 3T3, fibroblasts cells; Him (37°C), Himalayan 
melanocytes cultured at 37°C; Him (30°C), Himalayan 
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Fig. 2.2: Effect of a-MSH on tyrosinase activity. Skin 
explants were cultured for 6 hours in medium containing 
various a-MSH concentrations. They were assayed for tyrosi-
nase activity for 18 hours in the presence of [ 14cJ-tyrosine 
(0.5 µCi/ml) and cycloheximide (0.9 µM) (see materials and 
methods). Data points are averages of triplicate measure-
ments and represent one of the three experiments performed. 
A, albino; H, Himalayan, W, wild type. 
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incorporation into albino skins was subtracted and the 
results are presented in Table 2.2. The presence of a-MSH in 
the culture medium increased tyrosinase activity of both the 
Himalayan and wild type explants in a dose-dependent manner. 
At 10-9 M, a-MSH increased the Himalayan tyrosinase activity 
1.3 fold above control (i.e. [MSHJ=O), which increased to 4.1 
fold at a concentration of 10-4 M. Similarly, wild type 
tyrosinase activity increased from 1.5 fold at 10-9 M to 5.2 
fold at 10-4 M. It is interesting to note that the extent to 
which the wild type tyrosinase was activated by a-MSH was 
similar to that of the Himalayan mouse. 
2.3.5 The level of a-MSH action in cultured skin explants 
To determine whether the short-term activation of tyrosinase 
by a-MSH was depended on protein synthesis, cycloheximide 
(0.9 µM) was added in the culture medium prior to and 
together with the treatment with a-MSH. At this 
concentration (i.e. 0.9 µM), cycloheximide has been shown to 
effectively inhibit protein synthesis by 85% to 90% without 
affecting the incorporation of [ 14cJ-tyrosine due to 
tyrosinase activity (Gatsios and Kidson, 1986). The values 
representing the relative increase of tyrosinase activity at 
a particular a-MSH concentration were obtained by first 
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Table 2.2 
The effect of a-MSH on wild ty12e and Himalayan tyrosinase activity 
( 14 C] -tyrosine incorporation 
(cpm/ mg of dry weight) 
( MSH ) (M) Himalayan wild type 
Ex12eriment 1 
0 3 626 ± 237 5 271 ± 772 
10-9 6 758 ± 196 9 325 ± 115 
10-7 9 504 ± 484 11 402 ± 340 
10-5 11 033 ± 808 15 846 ± 834 
Ex12eriment 2 
0 1 616 ± 379 2 731 ± 439 
10-1 2 186 ± 526 4 719 ± 119 
10-5 4 528 ± 73 7 374 ± 471 
10-4 6 092 ± 602 9 668 ± 830 
Ex12eriment 3 
0 1 047 ± 300 1 643 ± 404 
10-1 3 666 ± 568 4 346 ± 80 
10-5 4 850 ± 517 5 553 ± 423 
10-4 11 233 ± 518 15 846 ± 536 
Mouse skin explants were cultured for six hours on glucose-agar 
media containing various concentrations of a-MSH (as specified in 
each experiment). They were then assaye~ for tyrosinase activity 
for 18 hours in the presence of a-MSH, ( 4cJ-tyrosine (0.5 µCi/ml) 
and cycloheximide (0 . 9 µM). Each data point represents the mean± 
range of activities from triplicate measurements which have been 
corrected for background incorporation in the albino skin. 
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subtracting the background incorporation of the albino skin, 
then dividing this value by control values. The results 
obtained show that a-MSH, at a concentration of 10-
5 M (which 
was the only tested concentration), caused a relative 4.6-
and 3.7-fold increase in the wild type and Himalayan 
tyrosinase activity respectively (Table 2.3). Similarly, the 
relative increase of tyrosinase activity in the wild type 
skin in the absence of cycloheximide was found to be 3.9-fold 
while that in the Himalayan skin was 3.2-fold. These 
findings suggest that the increase in tyrosinase activity in 
response to a-MSH in wild type and Himalayan mice is not due 
to de novo synthesis of new enzyme molecules. 
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TABLE 2.3 
The effect of a-MSH on tyrosinase activity in the presence of a 







Relative increase of tyrosinase activity 
above control 
Himalayan wild tyee 
+cHa -CH +CH CH 
1. 0 1. 0 1. 0 1.0 
N.Da 1. 3b N.D. 1. 5 
N.D. 2.1 N.D. 2.5 
3.7 3.2 4.6 3.9 
N.D. 4.1 N.D. 5.2 
Mouse skin er~lants were cultured for 6 hours on agar medium 
containing [ CJ-tyrosine (0.5 µCi/ml) with or without 
cycloheximide (0.9 µM) and various concentrations of a-MSH. They 
were assayed for tyrosinase activity for 18 hours and processed as 
described in materials and methods. The values presented here are 
averages of relative increase of t~rosinase activity above control 
from three s 6parate experiments. CH, cycloheximide N.D., not determined. , value does not significantly differ from control (P 
> 0. 05) . 
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2.4 DISCUSSION 
2.4.1 Development of a sensitive radiometric assay 
The aim of the work presented in this chapter was to 
investigate the effect of MSH on tyrosinase activity in mouse 
skin melanocytes in vitro. In order to carry out this 
investigation, a suitable assay had t ·o be established. The 
assay should make it possible to: 
(a) Monitor precisely the concentration of exogenous MSH 
and to 
(b) Detect different levels of tyrosinase activity due 
varying hormonal concentrations. 
The skin culture radiometric assay developed by Gatsios and 
Kidson {1986) satisfies the conditions stated above. Before 
using this assay, it was first necessary to asses the 
sensitivity of this assay. To do this, the temperature-
sensitivity of the Himalayan tyrosinase was exploited. 
Tyrosinase activity was measured in cultured skin explants of 
Himalayan mice previously housed under different temperature 
conditions (i.e. 15°C and 22°C). As expected with the 
Himalayan mutant, this assay showed a 31% to 47% increase in 
tyrosinase activity in mice housed at 15°C compared to those 
at 22·c. However, when the radiometric assay described by 
Hearing and Ekel {1976) was used, tyrosinase activity in a 
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crude homogenate of Himalayan mice housed at 15°C was found 
to be 55% to 117% above those at 22 · c. Considering the fact 
that in cultured skin, the measurement of tyrosinase activity 
(i.e. [14cJ-tyrosine uptake) depends on the diffusion rate of 
substances dissolved in agar, this assay compares well with 
that of Hearing and Ekel (1976). The sensitivity of this 
assay and the fact that one can concurrently measure 
tyrosinase activity during the treatment with hormones has 
made this assay suitable to fulfil the aims of this study. 
2.4.2 Differences in tyrosinase activity in cultured skin 
and crude homogenate 
A striking observation made in this study is that in cultured 
skin (in vivo), the wild type tyrosinase activity was found 
to be twice that of the Himalayan mouse, whereas in a crude 
homogenate (in vitro), the ratio of wild type to Himalayan 
tyrosinase activity was in most cases found to be 
approximately 13:1 (Table 2.1). In a similar study, the wild 
type (C57BL6J-C/C) tyrosinase activity measured by the assay 
method of Pomerantz (1966) in a crude homogenate, was found 
to be 100 fold higher than that of the Himalayan mutant 
(Halaban et al., 1988). Considering the result that in skin 
culture, the ratio of the wild type to Himalayan tyrosinase 
activity was found to be 2:1, it would be logical to expect 
the same ratio even in vitro. Since the actual ratio 
c~ 13:1) significantly deviated from the expected ratio 
(2:1), what do these results suggest? 
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First, it should be noted that the de novo form of 
tyrosinase, T3 , as well as the glycosylated form, T1 , are 
inhibited by the indole blocking factor in the cytoplasm 
(Hearing et al., 1982) and are therefore inactive. Thus, in 
vivo, melanin formation is restricted to the T4 form which is 
found in the melanosome (Seiji, 1967; Miyakazi, 1971; Hearing 
et al., 1982; Hearing & Jimenez, 1987). The skin culture 
radiometric assay, which mimics the in vivo situation, 
measures only T4 form of the enzyme. However, in the in 
vitro assay, all isozymes (T3 , T1 , and T4 ) are released into 
the homogenate and have been shown to be active (Hearing et 
al., 1981). This might explain the difference between the 
results obtained when comparing the in vitro and skin culture 
assays and suggests that the wild type skin contains a higher 
level of accumulated precursor forms of T3 and T1 . This 
proposition justifies the much higher levels of wild type 
tyrosinase activity in a crude homogenate as all the isozymes 
are active. These results are important because they provide 
some clue to the effect that the de novo processing of the 
wild type tyrosinase could be different to that of the 
Himalayan mutant. 
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2.4.3 The effect of a-MSH on tyrosinase activity in skin 
explants 
The injection of a-MSH into agouti and brown mice has 
previously been shown to stimulate melanin synthesis and 
deposition into the growing hair of these animals (Gershwind 
& Huseby, 1966; Gershwind et al., 1972; Tamate & Takeuchi, 
1984; Thody et al., 1984; Burchill & Thody, 1986; Burchill et 
al., 1986; 1988). A pilot study carried out in our 
laboratory revealed that the injection of a-MSH into living 
Himalayan mice also results in the darkening of hair. In 
order to study the mechanism of MSH action in depth, which is 
the key aim of this study, it was of absolute necessity to 
quantify more accurately this effect of a-MSH on the 
Himalayan hair in vitro. To meet this condition, the 
sensitive skin culture radiometric assay fully described 
earlier was used to measure the levels of skin tyrosinase 
activity due to a-MSH stimulation. In addition to the 
Himalayan mouse, the effect of a-MSH was also investigated in 
the wild type and the albino mice. 
Results showed that over a period of 24 hours, a-MSH 
stimulated the wild type and Himalayan tyrosinase activity in 
a dose-dependent manner, but had no effect on the albino 
tyrosinase (Table 2.2; Fig. 2.2). This activation of wild 
type and Himalayan tyrosinase by a-MSH was found to be 
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exclusively post-translational, since this response was not 
reduced in the presence of cycloheximide (Table 2.3). These 
results are in agreement with previous reports on melanoma 
cells (Wong & Pawelek, 1975; Korner & Pawelek, 1977) and in 
conflict with reports that MSH stimulates the de novo 
synthesis of tyrosinase (Fuller & Viskochil, 1979; Halaban et 
al., 1984; Fuller et al., 1987; Kwon et al., 1988; Honganson 
et al., 1989). The post-translational activation of the 
Himalayan tyrosinase by a-MSH is particularly interesting, 
since the enzyme in this mutant has previously been shown to 
be less active at normal mammalian body temperatures than at 
lower temperatures (Kidson & Fabian 1979, 1981). How can the 
post-translational activation of the Himalayan tyrosinase by 
a-MSH be explained? 
The first possibility is that MSH acts through the post-
translational removal of an endogenous tyrosinase inhibitor. 
Support for this hypothesis is provided by the following 
evidence. In the first place, Kidson and Fabian (1981) 
proposed that the lower tyrosinase activity in the Himalayan 
mutant is due to a temperature-induced conformational change 
of tyrosinase, resulting in increased affinity between the 
enzyme and its inhibitor. The presence of an inhibitor in 
pigment cells has also been reported for human melanocytes 
(Quevedo & Isherwood, 1960; Chian & Wilgram, 1967; Vijiyan, 
1982) and melanoma cells (Cooper & Mishima, 1967; Hamada & 
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Mishima, 1972; Satoh & Mishima, 1967; Korner & Pawelek, 1977; 
Fuller et al., 1988). Treatment of mouse melanoma cells with 
a-MSH has been shown to result in very low levels of indole 
blocking factor (an endogenous tyrosinase inhibitor) and 
increased levels of dopachrome conversion factor (DCF) when 
compared to untreated cells (Hearing et al., 1982). 
Furthermore, recent evidence from studies in which dopachrome 
conversion factor and dopa oxidase activities were separated 
by sucrose density centrifugation, clearly demonstrated that 
MSH enhances DCF activity in melanoma cells (Pawelek, 1989). 
Similarly, Korner & Pawelek (1977) have demonstrated a MSH-
mediated phosphorylation of a tyrosinase inhibitor in S91 
melanoma cells, resulting in an inactivation of that 
inhibitor. It appears therefore that in general, a-MSH 
stimulates the activity of DCF which may in turn displace the 
IBF. Interestingly, the results of the present study have 
shown that the increase of the wild type and Himalayan 
tyrosinase activity caused by a-MSH was similar (Fig. 2.2), 
which suggests the presence an inhibitor even in the skin of 
the wild type. The binding affinity of this inhibitor to the 
wild type tyrosinase appears to be lower than that of the 
Himalayan as shown by a higher basal enzyme activity in the 
former mouse. Furthermore, the failure of a-MSH ~o activate 
the albino tyrosinase suggest that the absence of enzyme 
activity in this tissue is not caused by endogenous 
inhibitors. On the basis of these findings, it is possible 
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that at 37°C, a-MSH could activate the Himalayan tyrosinase 
through the removal of an endogenous inhibitor (the indole 
blocking factor) and facilitate the binding of the dopachrome 
conversion factor which promotes melanogenesis via some 
unknown mechanism (see Fig. 2.3). 
A second hypothesis for the mechanism of MSH action in the 
Himalayan mouse is provided by the recent finding that the 
lower tyrosinase activity at 37°C in this mutant, could be 
due to an underglycosylated enzyme (Halaban et al., 1988). 
The implication of this result may be that the hormone could 
also promote the glycosylation of the enzyme in this mutant. 
In light of this, the extent to which glycosylation could 
influence the activational status of the Himalayan tyrosinase 
is investigated in the following chapter. 
2.4.4 Difficulties in culturing murine melanocytes 
Culturing of mouse non-malignant melanocytes in vitro, was 
for a long time unsuccessful due to: 
(a) The difficulty to isolate melanocytes from skin caused 
by the abundance of acellular tissue in mouse skin. 
(b) Failure to select effective mitogens. 




Fig. 2.3: Digrammatic representation of the mechanism of MSH 
action involving the removal of indole blocking factor. This 
scheme shows a possible mechanism of MSH whereby the hormone 
mediates the removal of an endogenous inhibitor (IBF) and 
facilitates the binding of dopachrome conversion factor 
(DCF) • 
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Just recently, Tomita et al (1987) developed a technique that 
overcom~these problems. Using this technique, t h e digestion 
of skin with 0.25% trypsin in DMEM was shown to an effective 
procedure to optimally release melanocytes. In addition, the 
combined mitogenic action of TPA, IBMX and human placental 
extract was demonstrated to be necessary for the continued 
survival of mouse melanocytes in vitro. Finally, the use of 
Geneticin, an antibiotic which selectively kill fibroblasts, 
was recommended as a reliable way of eliminating fibroblasts. 
In the present study, initial attempts to isolate skin 
melanocytes using the trypsin-collagenase procedure described 
earlier in this chapter, were found to be unsuccessful 
because: 
(a) Not many cells were released from skin after digesting 
with trypsin and collagenase for an hour. 
(b) When the digestion period was increased to 2 hours, very 
few cells survived. 
To overcome these problems, the method developed by Tamura et 
al. (1987) was refined and used to isolate skin melanocytes. 
This method proved to be effective since a reasonable 
proportion of viable cells was released from the skin. 
Isolated melanocytes were subsequently grown in TIP medium 
originally proposed by (Tamura et al., 1987). The successful 
culturing of melanocytes in this culture medium confirmed the 
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effectiveness of mitogens it contains in supporting the 
growth of murine melanocytes in vitro. However, as noted by 
Tamura et al. (1987), it was also confirmed in this study 
that only dermal melanocytes survived in the TIP medium as 
epidermal melanocytes routinely died after five days in 
culture. These observation could suggest that, in addition to 
mitogens present in this culture medium, the dermal tissue 
debris could be a source of other mitogens that are necessary 
for the survival of melanocytes. The surviving dermal 
melanocytes were treated with 100 µg/ml of Geneticin, a dose 
recommended to be effective in killing contaminating 
fibroblasts. Despite the use of Geneticin, it was not 
possible to be sure that pure melanocytes were ultimately 
obtained. In conclusion, it is worth emphasizing that this 
technique was difficult to master. 
CHAPTER III 
THE EFFECT OF UNDERGLYCOSYLATION AND ENHANCEMENT OF 





In the previous chapter, an hypothesis that a-MSH activates 
Himalayan and wild type tyrosinase by removing an endogenous 
inhibitor (the indole blocking factor) was proposed. This 
inhibitor could be more tightly bound to the Himalayan 
tyrosinase than the wild type as shown by higher basal enzyme 
activity in the latter. In addition to endogenous 
inhibitors, it has also been recently reported that reduced 
Himalayan tyrosinase activity could be due the deficiency of 
N-linked glycosylation (Halaban et al., 1988). In the light 
of this, the present chapter has investigated the ~ossibility 
that the activation of the Himalayan tyrosinase by a-MSH 
could involve glycosylation. Based on the assumption that 
low Himalayan tyrosinase activity results from under-
glycosylation, this chapter examines whether the missing 
sugars are core or terminal residues and to what extent these 
sugar residues affect tyrosinase activity 
Tyrosinase is known to be a glycoprotein with four to six N-
linked glycosylation sites (Hearing & Jimenez, 1987; Kwon et 
al., 1988, 1989), but not much is known about the functional 
role of the sugar residues. For many glycoproteins, 
carbohydrate moieties confer important physical properties 
such as protease resistance (Schwartz et al., 1976; Older et 
al., 1978), charge and water-binding capacity (Paulson, 
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1989), conformational stability (Stanely, 1987), intra-
cellular signal for localization to specific organelles (von 
Figura et al., 1979; Smith & Baenzinger, 1988) and enzyme 
activity (Paulson et al., 1989). 
Although the biosynthesis of glycoproteins is complex, the 
unique nature of the linkages between the protein core and 
the carbohydrate side chains (i.e. N- or o- linked sugars), 
have simplified the study on the role of these sugars of 
glycoproteins. The N- or asparagine- linkages involve the 
amide group of the amino acid, asparagine, with the carbon-1 
of N-acetylglucosamine (Fig. 3.1). The 0-linkages are formed 
via the reaction of the hydroxyl group of serine or threonine 
and the reducing carbon of the sugar c1 or c2 (Fig.3.1). The 
availability of drugs such as tunicamycin and glucosamine 
which preferentially inhibit the synthesis of N-linked core 
sugars, has recently spurred a number of investigators to 
endeavor to unravel the functions of the carbohydrate 
moieties of glycoproteins. As shown in Figure 3.2, 
tunicamycin blocks the addition of N-acetylglucosamine to the 
carrier molecule (dolichol phosphate), the first step in the 
formation of the core oligosaccharide. Glucosamine acts at a 
later step in this biosynthetic pathway by inhibiting the 
transfer of mannose from dolicholmannose and guanosine 
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Fig. 3.1: Scheme showing the nature of o- and N-linkages of 
glycoproteins. Note the core sugars which are shown in the 
dark background and terminal sugars in the light background. 
GlcNAc, N-acetylglucosamine; Man, mannose; Gal, galactose; 
Sial, sialic acid residues. 
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Fig. 3.2: Scheme showing the inhibition sites of 
glycosylation inhibitors (After Irnokawa & Mishirna, 1988). 
GlcNAc, N-acetylglucosarnine; Man, rnannose; NeuAc, N-
acetylneurarninate (sialic acid). 
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Lectins, which are carbohydrate-binding proteins from plants, 
are widely used to investigate the biological function of a 
broad spectrum of glycoproteins (Stanley, 1983). The 
concanavalin A lectin affinity chromatography (which 
specifically binds to internal and non-reducing a-mannosyl 
residues) has been used to confirm the known effects of 
glucosamine and tunicamycin on tyrosinase (Imokawa & Mishima, 
1985). Tyrosinase prepared from melanoma cells cultured in 
the presence of either glucosamine (1 mg/ml) or tunicamycin 
(0.4 µg/ml) was shown not to bind to lectins. These results 
showed that these drugs inhibited the synthesis of N-linked 
core sugars which may be involved in the binding of 
tyrosinase to the melanosome (Hearing et al., 1981). 
Furthermore, the ultra-structural examination of glucosamine-
or tunicamycin-treated melanoma cells revealed a selective 
loss of melanin in premelanosomes, suggesting that the N-
linked core sugars were responsible for the intracellular 
localization of tyrosinase. This subject is reviewed in 
detail in Chapter 1. 
Since it is presently not known whether reduced tyrosinase 
activity in the Himalayan mutant is due to the deficiency in 
core or terminal glycosylation, this study has attempted to 
dissect and study each component separately. The ability of 
the Himalayan tyrosinase to incorporate mannose or N-
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acetylglucosamine (which are core sugars) has been shown to 
be significantly lower than that of the wild type enzyme 
(C57BL/6J and BlO.BR strains) (Halaban et al., 1988). In 
this study, the effect of core glycosylation on wild type 
(C57BL/6) and Himalayan tyrosinase activity was first 
studied. To carry out this study, the specificity of 
glucosamine was exploited to investigate the inhibition of 
mannose incorporation (see Fig. 3.2) on tyrosinase activity 
of these mice. If diminished levels of Himalayan tyrosinase 
activity results from a deficiency in core sugars, 
glucosamine should have a differential effect in reducing the 
Himalayan and wild type tyrosinase activity. 
In addition to core glycosylation, the role of terminal 
sugars on the wild type and Himalayan tyrosinase activity was 
also explored. As a means of investigating this possibility, 
the sialic acid residues were chosen for initial 
investigation because, by virtue of being charged, they are 
likely to influence the conformation of any glycoprotein and 
thereby alter its enzymatic activity. Neuraminidase (an 
enzyme which cleaves the terminal sialic acid sugars) (Fig. 
3.2), has been used to investigate the role of these sugars 
• 
on wild type and Himalayan tyrosinase activity. If the 
Himalayan tyrosinase is inherently devoid of terminal sialic 
acid sugar residues, one can expect neuraminidase to cause a 
differential decrease on the activity this enzyme in these 
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mice. On the other hand, the addition of sialic acid 
residues should cause a differential increase of the 
Himalayan and wild type tyrosinase activity. Retinoic acid, 
a vitamin A derivative, has previously been shown to increase 
the activity of tyrosinase in melanoma cells {Lotan et al., 
1978; Lotan & Lotan, 1980), by stimulating the activity of 
sialyltransferases (enzymes that mediate the addition of 
sialic acid residues) {Lotan et al., 1984). Based on these 
findings, the possibility that retinoic acid could reverse 
the effect of neuraminidase on wild type and particularly on 
the Himalayan tyrosinase activity was explored. 
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3.2 MATERIALS AND METHODS 
3.2.1 Measurement of basal and a-MSH-stimulated tyrosinase 
activity in the presence of glucosamine 
Wild type and Himalayan skin explants were cultured for six 
hours on agar medium with or without a-MSH (10-5 M, 
Boehringer-Mannheim) or/and glucosamine (5 mM) and tyrosinase 
activity was assayed for 18 hours using the skin culture 
radiometric assay described previously (paragraph 2.2.2.2.). 
Glucosamine was added in the culture medium during the 
culture and assay period. 
3.2.2 Measurement of tyrosinase activity in the presence 
of neuraminidase 
Neuraminidase (EC 3.2.1.18) (from Clostridium perfringens, 
Boerhringer-Mannheim) was added to a 20 ooog supernatant of 
wild type and Himalayan crude homogenates to a final 
concentration of 0.25 µg/ml. Tyrosinase activity was 
concurrently measured for 5 hours by means of an in vitro 
radiometric assay described in paragraph 2.2.1.2. 
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3.2.3 Quantitation of tyrosinase activity in the presence of 
retinoic acid in wild type and Himalayan skin 
Wild type and Himalayan skin explants were culture for six 
hours on agar medium containing retinoic acid (10 µM) and 
with or without cycloheximide (0.9 µM). Tyrosinase activity 
was assayed for 18 hours in the presence of retinoic acid, 
[ 14cJ-tyrosine (0.5 µCi/ml) and cycloheximide as described 
previously (see skin culture radiometric assay, paragraph 
2.2.2.2.). 
3.2.4 Determination of retinoic acid-stimulated tyrosinase 
activity and cell density in Bl6 melanoma cells 
Bl6 melanoma cells were cultured for 72 hours in DMEM with or 
without various concentrations of retinoic acid (lo-6 M to 
10-5 M), as specified in each experiment. No cycloheximide 
was added during this culture period. After culture, cells 
were lifted with 0.05% EDTA-0.02% trypsin and a crude 
homogenate prepared as described in paragraph 2.2.2.1. 
Tyrosinase activity of the 20 000 g supernatant was measured 
using the in vitro radiometric assay. Cell density was 
determined by means of a haemocytometer. Percentage decrease 
in cell density was calculated in relation to control cells 
using the following formula: 
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[(Cc - CR.A)/ Cc x 100], where Cc, cell density in control 




3.3.1 The effect of glucosamine on tyrosinase activity in 
cultured skin explants 
Wild type and Himalayan skin explants were cultured for 6 
hours in media with or without a-MSH and/or glucosamine and 
assayed for tyrosinase activity as described in materials and 
methods. This experiment was repeated twice and the results 
of the representative experiment are shown in Figure 3.3. 
The basal and a-MSH stimulated tyrosinase activity was 
effectively reduced by glucosamine after 24 hours in culture 
in both the Himalayan and the wild type. IThe average 
relative decrease in basal tyrosinase activity in the 
Himalayan mutant was 32% and that of the wild type was found 
to be 35%. Similarly, the reduction of a-MSH stimulated 
tyrosinase activity by glucosamine was 44% and 51% in the 
Himalayan mutant and wild type respectively. The activity in 
the albino skin was not affected by either glucosamine or a-
MSH. 
3.3.2 The role of neuraminidase on wild type and 
Himalayan tyrosinase activity 
Neuraminidase (0.25 µg/ml) was added to 20 ooo g supernatant 
of a crude homogenate of wild type and Himalayan skins, then 
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Fig. 3.3: Effect of glucosamine on basal and a-MSH-
stimulated tyrosinase activity. Skin explants of 4-5 day old 
mice were cultured on agar media with or without a-MSH 
(lo-5 M) or/and glucosamine (5.5 mM) for six hours and 
assayed for tyrosinase activity for 18 hours (see materials 
and methods). This experiment was carried out twice with 
similar results. Each value is a mean± S.D. from three 
measurements and all values are significantly different from 
each other (P 5 0.04). A, albino; H, Himalayan; W, wild type. 
(~), control; (tZ83), + glucosamine - a-MSH; 
(FJI), - glucosamine + a-MSH; (Ill), + glucosamine + a-MSH. 
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assayed for tyrosinase activity 5 hours (see materials and 
methods). This experiment was carried out twice with similar 
results. It was found that the average decrease in wild type 
tyrosinase activity in the presence of neuraminidase was 21% 
(Table 3.1). Similarly, the average reduction of the 
Himalayan tyrosinase activity was found to be 15%. These 
results showed that neuraminidase reduced the activity of 
wild type and Himalayan tyrosinases to the same extent. 
3.3.3 The effect of retinoic acid on tyrosinase activity and 
cell density in B16 melanoma cells 
It has been reported that retinoic acid caused an increase in 
tyrosinase activity and a simultaneous inhibition of growth 
in human (Hs 939) and mouse (S91) melanoma cells (Lotan et 
al., 1978; Lotan & Lotan, 1980). In this study, this effect 
of retinoic acid on tyrosinase activity and cell density was 
confirmed using B16 mouse melanoma cells. Melanoma cells 
were cultured for 72 hours in cycloheximide-free DMEM medium 
containing various concentrations of retinoic acid (see 
materials and methods). Under these conditions, retinoic acid 
markedly increased tyrosinase activity in a dose-dependent 
manner (see Fig. 3.4). At a concentration of 10-8 M, 
retinoic acid caused a 26% increase in tyrosinase activity 
above control and at a molar concentration of 10-6 , the drug 
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Table 3.1 








[1 4cJ-tyrosine incorporation 
(cpm/µg of protein of homogenate) 
wild type 
1 497 ± 57 
1 140 ± 85 
10 020 ± 860 
8 090 ± 195 
Himalayan 
1 345 ± 6 
1 168 ± 87 
971 ± 150 
802 ± 143 
Neuraminidase was added to wild type and Himalayan crude homogenates t 
a final concentration of 0.25 µg/ml and tyrosinase activity assayed fo 
5 hours using in vitro radiometric assay (see materials and methods). 
Each data point is a mean two measurements± S.D. All control values 
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Fig. 3.4: Effect of retinoic acid on tyrosinase activity and 
cell density in melanoma cells. B16 melanoma cells were 
cultured in DMEM for 72 hours with various concentrations of 
retinoic acid. Tyrosinase activity and cell density were 
determined as described in materials and methods. Values are 
means of three measurements± S.D. 
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increased tyrosinase activity by 45%. As expected, results 
showed that in addition to an increase in tyrosinase 
activity, retinoic acid also caused a dose-dependent 
inhibition of growth. The results are presented in Table 3.2 
and Figure 3.4. At a concentration of 10-6 Mand 10-5 M, 
retinoic acid induced a 32% and 47% growth inhibition 
respectively. 
3.3.4 The effect of retinoic acid on tyrosinase activity 
in skin explants. 
This experiment was carried to investigate the possibility 
that retinoic acid could reverse the effect of neuraminidase 
by differentially increasing the wild type and Himalayan 
tyrosinase activity. Skin explants of wild type and 
Himalayan mice cultured for six hours on retinoic acid-
supplemented agar medium with and without cycloheximide and 
were assayed for tyrosinase activity as described in 
materials and methods. In the presence of cycloheximide, 
there was no significant difference in wild type and 
Himalayan tyrosinase activity between retinoic acid-treated 
and control skin explants (P ~ 0.06) (Fig. 3.5). In the 
absence of cycloheximide, retinoic acid still failed to 
increase the Himalayan tyrosinase activity significantly when 
compared to control (P > 0.05), 
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Table 3,2 
Effect of retinoic acid on cell density in B16 melanoma cells. 
cell density 
[RA) (M) exp 1 exp 2 average 
0 12.3 X 106 10.5 X 10 6 11. 4 ± 0.9 X 10
6 
10-6 8.0 X 106 7.3 X 10 6 7.65 ± 0.4 X 106 
10-5 5.8 X 106 6.1 X 10 6 5.95 ± 0.2 X 106 
Cells were cultured for 72 hours in DMEM containing various 
concentrations of retinoic acid and cell density was determined using 
haemocytometer as described in materials and methods. Average values 
represent a mean of two measurements± S.D. All experimental values 
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Fig. 3.5: Effect of retinoic acid on tyrosinase activity in 
skin explants in the presence of cycloheximide. Wild type 
and Himalayan skin explants were cultured six hours on agar 
medium with or without retinoic acid (10 µM) and 
cycloheximide (250 µg/ml). Tyrosinase activity was assayed 
for 18 hours in the presence of [
14cJ-tyrosine (0.5 µCi/ml) 
and cycloheximide as detailed in materials and methods. The 
background incorporation in the albino skin has been 
subtracted. •, values not significantly different from 
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Fig. 3.6: Effect of retinoic acid on tyrosinase activity in 
skin explants in the absence of cycloheximide. Wild type and 
Himalayan skin explants were cultured on cycloheximide-free 
agar medium with or without retinoic acid (10 µM) and assayed 
for tyrosinase activity as described in materials and 
methods. The background incorporation in the albino skin has 
been subtracted. lf, value not significantly different from 
control (P > 0.05). H, Himalayan; W, wild type. 
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In chapter two, the activation of the wild type and Himalayan 
tyrosinase by a-MSH was demonstrated and a theory was put 
forward that this activation involved the removal of 
endogenous inhibitor. In this chapter, another mechanism by 
which a-MSH could activate the Himalayan tyrosinase is 
considered. Recently, Halaban et al. (1988) reported that 
the Himalayan tyrosinase is deficient in N-linked 
glycosylation and proposed that this results in rapid 
degradation of this molecule at normal body temperature. 
This hypothesis was based on their finding that 
immunoprecipitated Himalayan tyrosinase corresponded to the 
molecular weight of an underglycosylated enzyme, whereas the 
wild type tyrosinase was predominantly in the fully 
glycosylated form. Secondly, the ability of Himalayan 
tyrosinase to incorporate [ 3HJ-glucosamine and [
3HJ-mannose 
significantly less than the wild type. 
If a-MSH is able to activate Himalayan tyrosinase as shown in 
the preceding chapter, the above results raise the 
possibility that a-MSH could act via glycosylation to 
activate the Himalayan and wild-type tyrosinase. 
In the hope of gaining a more detailed understanding of 
tyrosinase glycosylation, work in this chapter analyses the 
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role of the core and terminal sugars on tyrosinase activity. 
To investigate core glycosylation, the synthesis of N-linked 
core sugars was inhibited by treatment with glucosamine, then 
the activity of tyrosinase measured. It was found that at a 
concentration of 5.5 mM, glucosamine reduced basal and a-MSH-
stimulated tyrosinase activity to approximately the same 
degree in both the wild type and Himalayan mutant (Fig. 3.3). 
These results may be explained in the following way: As N-
linked core sugars determine the intra-cellular destination 
of tyrosinase, reduced tyrosinase activity in the presence of 
glucosamine results in the interruption of tyrosinase 
translocation to the melanosome (Imokawa & Mishima, 1985). 
Since tyrosinase activity in melanocytes is, in part, 
regulated by the rate of turnover of the enzyme (Jimenez et 
al., 1988), in the presence of glucosamine, no tyrosinase 
b~ 
would~transported to the melanosome to replace the degraded 
enzyme. If the Himalayan tyrosinase is inherently deficient 
in N-linked core sugars, less enzyme would transferred to the 
melanosome as compared to the wild type. Under these 
conditions, further inhibition in the transport of wild type 
and Himalayan tyrosinase induced by glucosamine should reduce 
tyrosinase activity of these mice differentially. Since this 
was not found to be the case, the results suggest that the 
mutation in the Himalayan mouse does not involve core sugars. 
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It is interesting to note that the decreased activity of 
tyrosinase resulting from the inhibition of intra-cellular 
transport of the enzyme by glucosamine is similar to that 
described in the chinchilla mutant in vivo, which has an 
inherent defect to transfer tyrosinase to melanosomes 
(Imokawa & Mishima, 1988). In this study, it was shown by 
organ culture technique and electron microscopy that 
theophylline and dbc-AMP enhanced the transfer of tyrosinase 
to the melanosome in vitro, whereas MSH failed to do so. The 
possible mechanism of action of theophylline and dbc-AMP was 
not investigated. These findings are in accord with those of 
the present study, as a-MSH did not increase the wild and the 
Himalayan tyrosinase activity in the presence of glucosamine. 
Since the inhibition of the synthesis of N-linked core sugar 
equally reduced the Himalayan and wild type tyrosinase 
activity, the role of terminal sugars were subsequently 
investigated. In order to investigate this possibility, the 
role of sialic acid residues on the Himalayan and wild type 
tyrosinase activity was investigated using neuraminidase 
(which hydrolyzes terminal sialic acid residues). The key 
reason behind the use of sialic acid was that these sugars 
are charged and their removal as a consequence of a mutation 
in vivo or in vitro is likely to alter the nett charge of 
tyrosinase, which can in turn change the conformational 
dynamics of the enzyme. Results showed that in the presence 
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of neuraminidase, the average reduction of the wild type and 
Himalayan tyrosinase was 21% and 15% respectively. These 
results are in perfect agreement with those Hearing et al 
(1981), whereby neuraminidase was shown to reduce purified 
tyrosinase from melanoma cells by 10% to 20%. The similar 
reduction of the wild type and Himalayan tyrosinase activity 
suggest that reduced tyrosinase activity in the latter mouse 
is not caused by sialic acid sugar residues. 
Due to the fact that the action of neuraminidase did not 
result in the differential reduction of the wild type and 
tyrosinase activity, the effect of retinoic acid (which 
facilitates the addition of sialic acid residues) was next 
investigated. The main reason of using retinoic acid was to 
investigate the possibility that it might activate the 
Himalayan tyrosinase to a higher level that the wild type 
enzyme. Previously, retinoic acid has been shown to activate 
human (Lotan & Lotan, 1982) and mouse (Lotan et al., 1980) 
melanoma cells. As a preliminary study, this effect of 
retinoic acid was verified by demonstrating its dose-
dependent increase of tyrosinase activity in B16 melanoma 
cells (Fig. 3.4). Having confirmed these results, the effect 
of retinoic acid was then investigated on the wild type and 
Himalayan tyrosinase activity. Skin explants of wild type 
and the Himalayan mouse were cultured in the presence of 
retinoic acid (10 µM) with or without cycloheximide. 
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Retinoic acid had no effect on the wild type and Himalayan 
tyrosinase activity in the presence of cycloheximide 
(P ~ 0.06) (Fig. 3.5), whereas in the absence of 
cycloheximide, the wild type tyrosinase activity slightly 
increased (i.e. 1.3-fold) (Fig. 3.6). The finding that 
retinoic had no effect on the Himalayan tyrosinase activity 
and slightly activated the wild type tyrosinase may be 
incorrect due to inherent limitations of the skin culture 
assay. More specifically, the effectiveness of retinoic acid 
at this concentration on the distant and scattered skin 
melanocytes is much less than that in the culture medium, 
since its action is depended on the diffusion rate through 
the agar and the dermis and secondly, retinoic acid does not 
only stimulate the activity of sialyltransferases of 
tyrosinase, but also of other glycoproteins and glycolipids 
present in skin. 
Considering these conditions in cultured skin, it likely that 
our failure to detect the effect of retinoic acid could be 
due to the fact that it is diluted. Nevertheless, the 
finding that only the wild type tyrosinase activity was 
increased in the absence of cycloheximide suggests a protein 
synthesis-dependent activation of this enzyme. There is 
strong evidence in literature showing that retinoic acid 
exerts its effect by binding to a nuclear receptor (Giguere 
et al., 1987; Petkovich et al., 1987; Benbrook et al., 1988; 
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and Brand et al., 1988) which has recently been cloned and 
sequenced in B16 melanoma cells (Dally & Redfern, 1989). In 
support of this evidence, is the reported nuclear 
localization of retinoic acid (Chytil, 1984; Lotan, 1984) 
Thus, a possibility exists that in mouse skin, retinoic acid 
could stimulate the transcriptional synthesis of new 
tyrosinase molecules that are subsequently glycosylated de 
novo. If that is the case, why is it that an increase in 
Himalayan tyrosinase activity could not be detected even when 
protein synthesis was not blocked? A small increase in 
tyrosinase activity due to the synthesis of new enzyme like 
that measured in the wild type skin (i.e. 1.3-fold), could 
not have been detected in the Himalayan mutant since at 37 °C, 
the enzyme is more tightly bound to inhibitors (see Chapter 
two). 
Although retinoic acid may increase tyrosinase activity by 
promoting the synthesis of new enzyme molecules, its 
mechanism of action still remains unclear. The retinoic 
acid-stimulated tyrosinase activity in melanoma cells has 
been shown in the present and other studies (Lotan et al., 
1978; Lotan & Lotan, 1980), to be concomitant with growth 
inhibition (see Fig. 3.4). This inhibitory effect of 
retinoic acid on growth has also been demonstrated in human 
epidermal cells (Hashimoto et al., 1985) and embryonal 
carcinoma cells (Plet et al., 1985). The elucidation of the 
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mechanism of action of retinoic acid is further complicated 
by its diverse effects including promotion of growth 
(Christophers, 1974; Marhle et al., 1981; Marhle & Gray, 
1983), morphological changes in melanoma cells (Lotan et al., 
1983) cancer prevention (Moon et al., 1983) and many other 
effects. However, there is substantial evidence in 
literature indicating that the inhibition of growth caused by 
retinoic acid in melanoma cells (Niles & Logues, 1979) and 
other cell types (Lee et al., 1976; Byus et al., 1977; Costar 
et al., 1978; Plet et al., 1985) could involve the type II 
regulatory subunit of c-AMP dependent kinase. In the 
presence of retinoic acid, this kinase has been shown to 
stimulate the activity of ornithine decarboxylase, an enzyme 
that contributes to the accumulation of cells in the G1 phase 
of the cell cycle (Jetten, 1984). These results suggest that 
retinoic acid may act via ornithine decarboxylase and the 
cell cycle to inhibit the growth of melanoma cells. Even if 
the activation of tyrosinase in melanoma cells, which is 
accompanied by inhibition of growth, has been shown to be 
cell cycle-dependent (Abdel-Malek et al., 1989), the 
relationship between retinoic acid, c-AMP dependent kinase, 
ornithine decarboxylase and cell growth remains to be 
investigated. Despite the fact that the precise mechanism of 
retinoic acid remains unknown, the possibility that it could 
share the same pathway with a-MSH may be ruled out because: 
(a) Unlike a-MSH, no rise in intra-cellular levels of 
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adenosine-3,5-monophosphate in response retinoic acid has 
been detected (Lotan et al., 1978). and (b) Even human Hs 
939 melanoma cells that are unresponsive to a-MSH, 
demonstrate a rise in tyrosinase caused by retinoic acid 
(Lotan & Lotan, 1980). 
In summary, under the experimental conditions of this study, 
it could not be confirmed that the Himalayan tyrosinase was 
underglycosylated compared to the wild type enzyme since: 
(a) Neuraminidase did not differentially reduce the Himalayan 
and wild type tyrosinase activity. and (b) Retinoic acid 
failed to reverse the effect of neuraminidase by activating 
the Himalayan tyrosinase more than that of the wild type. 
In view of the existing limitations of the assay method used 
in this study, these results need to be confirmed by directly 
testing the effect of retinoic acid on cultured Himalayan 
melanocytes. More importantly, the use of retinoic acid has 
provided some insight to the effect that the activation of 
wild type and Himalayan tyrosinase could involve the 
synthesis of new enzyme molecules. Thus, the role of 
transcription and translation of tyrosinase on the activity 








The evidence presented so far in this study has clearly 
demonstrated that the activation of tyrosinase in mouse skin 
melanocytes is at the level of post-translation. In chapter 
2, the post-translational activation of tyrosinase by a-MSH 
was demonstrated. In chapter 3, glycosylation was shown to 
be an additional parameter that regulates tyrosinase 
activity. The questions that the present chapter attempts to 
answer are: (1) Is the post-translational processing of 
tyrosinase in skin melanocytes the only control mechanism by 
which this enzyme is regulated? and (2) Does translation 
and/or transcription play a part in the regulation of 
tyrosinase activity in these melanocytes? 
When the present project was initiated, it was not known 
whether tyrosinase activity of normal and mutant mice used in 
this study was controlled at the level of translation or 
transcription. While this study was in progress, 
investigators in other laboratories were studying the same 
issues. The results presented in this chapter satisfactorily 
agree with some of these studies and others disagree. 
Earlier studies on melanoma cells have indirectly studied the 
role of translation and transcription on tyrosinase activity 
by making use of protein and RNA inhibitors respectively 
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(Wong & Pawelek, 1975; Fuller & Visckochil, 1979; Halaban et 
al., 1984; Fuller et al., 1987). Recently, Halaban et 
al. (1988) have investigated the translational regulation of 
tyrosinase by directly quantitating the total amount of 
enzyme using an anti-tyrosinase antibody. The levels of 
tyrosinase were measured in a variety of cultured mouse 
melanocytes including the wild type (BRlO.BR), Himalayan 
(ch;ch) and pink-eyed chinchilla (cch/cp) strains. Equal 
levels of immunoprecipitated tyrosinase were measured in the 
wild type and the Himalayan melanocytes, which were found to 
be four times higher than the quantity of albino and 
chinchilla enzyme. Although these results suggested the 
possible involvement of translation in the regulation of 
tyrosinase activity, it was not clear at this stage whether 
the levels of tyrosinase measured in these four mice were due 
to the differential expression of the tyrosinase gene. The 
answer depended on the accurate quantitation of rnRNA levels 
-
in these mice, which can now be done due ' to the recent 
success in the sequencing and cloning of tyrosinase cDNA's 
(Shibahara et al., 1986; Yamamoto et al., 1987; Kwon et al., 
1987, 1988) . 
Using the PTY-1 tyrosinase cDNA (Kwon et al., 1988), Halaban 
et al. (1988) continued their study by investigating the role 
of transcription on tyrosinase activity. This probe was used 
to measure levels of mRNA in cultured melanocytes of the wild 
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type, Himalayan and chinchilla mutant mice which were found 
to be the same in all the three genotypes. At the same time, 
Takeuchi et al. (1988) used the Tyrs cDNA (Yamamoto et al., 
1987) to measure the amount of rnRNA in the wild type 
(C57BL/6J-C/C) and albino skins. They also measured equal 
levels tyrosinase mRNA in both these mice. In another 
related study in which the pMT4 cDNA {Shibahara et al., 1986) 
was used, similar levels of mRNA were also found in the skins 
of the black and albino mice (Shibahara, 1988). More 
recently, the findings of Halaban et al (1988) were verified 
since the levels of RNA in cultured Himalayan melanocyte were 
shown to be the same as in the wild type (Kwon et al., 1989). 
Most importantly, in all of the above-mentioned studies, the 
same size of the hybridization signal was found (about 2.3 
kb), suggesting the lack of gross deletions in the tyrosinase 
gene of the mutant mouse strains used. In support of this 
idea, is the recent identification of a point mutation in the 
Himalayan mouse (Kwon et al., 1989). 
This study has made an attempt to investigate the extent to 
which the translation of tyrosinase is involved in the 
regulation of its activity. To carry out this aim, an anti-
tyrosinase antibody has been used to quantitate the abundance 
of tyrosinase in the skins of the normal wild type 
(C57BL/6J), Himalayan and albino mutant mice. In order to 
gain additional insight on how tyrosinase activity could be 
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regulated in vivo, the relationship between translational and 
transcriptional control mechanisms was investigated in these 
mice. To explore the role of the latter mechanism on the 
activity of tyrosinase, the levels of mRNA transcripts were 
measured in the skins of these three mice using tyrosinase 
cDNA's. 
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4.2 MATERIALS AND METHODS 
4.2.1 Purification of tyrosinase 
4.2.1.1 DEAE ion exchange chromatography 
The column was pre-washed with 10 mls of NaOH (pH 13). A 
crude cell homogenate was applied to 1.5 cm x 8.0 cm DEAE 
Sephadex ion exchange column, equilibrated with low salt 
buffer (20 mM Tris, pH 8) and allowed to run under the 
influence of gravity at a flow rate of 1 ml/min. The column 
was then washed with the low salt buffer until the effluent 
measured at o.o. 280 was~ O. The bound material was eluted 
with the high salt buffer (20 mM Tris+ 0.3 M NaCl, pH 8) and 
1 ml fractions were collected. Fractions containing high 
tyrosinase activity were identified using the 
spectrophotometric assay at _o.o. 475 (0.1 ml of each fraction 
was mixed with 0.9 ml of L-DOPA (lmg/ml) in phosphate buffer, 
then incubated for 2 hours at 37°C and tyrosinase activity 
measured hourly). Fractions with high tyrosinase activity 
were pooled and concentrated against polyethyleneglycol (PEG 
6000) and subjected to gel electrophoresis. 
4.2.1.2 Polyacrylamide gel electrophoresis without 
detergents 
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Electrophoresis was carried out by the method originally 
described by Davis (1964). Crude homogenate proteins from 
B16 melanoma cells were run in a 7.5% acrylamide gel in a 
0.025 M Tris/glycine buffer at 100 V for 3\ hours. After 
electrophoresis, gels were neutralized in phosphate buffer 
(0.5 M, pH 7.4) for\ an hour and thereafter stained with 
1 mg/ml of L-DOPA in phosphate buffer (0.1 M, pH 7.4). 
Tyrosinase stained as a dark band which appeared after 10 
minutes of incubation. Bands corresponding to various 
tyrosinase isozymes (T1 , T3 and T4 } were cut out, kept for 
raising antibodies while some were further analysed on an SOS 
gel. 
4.2.1.3 Analysis of purified tyrosinase isozymes on sos 
gels 
sos gel electrophoresis was carried out utilizing the 
discontinuous buffer system originally described by Laemmli 
(1970). Gel pieces of approximately 3 mm2 containing various 
tyrosinase isozymes were mixed with 20 µl sos sample buffer, 
layered into the wells of the gel and eletrophoresed for 
3 hours at 120 V. Standard molecular weight markers 
(Pharmacia) were run concurrently with the samples for 
molecular weight determination. Tyrosinase and other 
contaminating proteins were visualized by staining with 
Comassie blue. 
4.2.1.4 Molecular weight determination of purified 
tyrosinase 
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The distance migrated by tyrosinase and the standard 
molecular weight protein markers were measured. These values 
were fed onto the Enzfitter non-linear regression data 
analysis computer programme (Elsevier, 1987) which was used 
to calculate the molecular weight of tyrosinase. 
4.2.2 Immunization of animals 
Immunization of rabbits and guinea pigs was carried out at 
the Animal Unit, University of Cape Town Medical School. 
Non-immune sera was drawn before injecting with tyrosinase. 
The T4 tyrosinase isozyrne contained in a
crylamide, was 
subcutaneously injected into guinea pigs. Rabbits were 
injected with all isozyrnes (T3 , T1 & T4 ). Both guinea pigs 
and rabbits were boost-injected 2 weeks after the initial 
injection. The immune sera was drawn a week after the 
boosting and tested for the presence of tyrosinase antibodies 
using the western blot technique. 
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4.2.3 Western immunoblot technique 
Wild type, Himalayan, albino and melanoma crude homogenate 
proteins mixed with sos sample buffer in 2:1 ratio, were 
separated on an sos gel and transferred to the nitrocellulose 
membrane (0.45 µM, Schleicher & Schull) according to Towbin 
et al. (1979). The proteins were transferred using a B2300-
protein transfer chamber (Consort) filled with blotting 
buffer (190 mM glycine; 50 mM Tris, 0.2% methanol, pH 8.3) at 
100 mA, 14 V overnight. Sheets containing transblotted 
molecular weight markers were washed for\ an hour in 0.1 M 
phosphate buffer (pH 7.4), stained with Indian ink for 1\ 
hour and destained in di~tilled water. Sheets onto which 
crude homogenate proteins were transblotted, were incubated 
for 2 hours at room temperature in a mixture of Tris buffer 
saline (TBS), 3% Tween, 3% fat-free milk and 1:100 goat 
serum. After washing with 3% fat-free milk in TBS (2 x 5 
min), the sheets were incubated overnight at room temperature 
with 5 mls of TBS containing a tyrosinase polyclonal antibody 
in serum (1:250). After this step, the sheets were processed 
using either the 4-chloro-1-napthol/hydrogen peroxide or 
immunogold staining procedures as described below. 
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4.2.3.1 The 4-chloro-1-napthol/hydrogen peroxide staining 
method 
After the primary antibody reaction, the sheets were washed 
in 0.05% tween-20 in TBS (2 x 15 minutes), then incubated 
with peroxidase-conjugated goat-antirabbit secondary antibody 
(1:500) for an hour. After rinsing twice for 5 minutes each 
in TBS, sheets were finally incubated with 0.5 mg/ml 4-
chloro-1-napthol, 16% methanol, 0.015% hydrogen peroxide in 
TBS. The reaction was terminated by washing with water and 
the sheets were air-died and stored until photographed. 
Quantitation of positive staining bands was determined by 
densitometric scanning at 500 nm in a Cliniscan densitometric 
equipment (Helena laboratories, Texas) 
4.2.3.2 The immunogold staining method 
This immune-staining procedure originally described by 
Moeremans et al. (1984) is reported to be at least ten times 
more sensitive than the 4-chloro-1-napthol/hydrogen peroxide 
staining method. After incubation with the primary antibody, 
the nitrocellulose sheets were washed in TBS (3 x 10 
minutes), then incubated with a gold labelled secondary 
antibody (lµg/ml) diluted in TBS supplemented with 0.4% 
gelatin. Thereafter, the strips were washed with TBS (2 x 10 
min) on a rocking table and air-dried. Subsequently, they 
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were washed in distilled water (2 x 10 min) and in 0.2 M 
citrate buffer (pH 3.85) for 2 minutes to remove chloride 
ions then incubated with the physical developer protected 
from light with aluminium foil. The physical developer was 
prepared as follows: 60 ml of H2o was mixed with 10 ml stock 
citrate buffer (2 M, pH. ± 4.85), 0.85 g hydroquinone in 15 ml 
H2o, 0.11 g of silver lactate in 15 ml). Hydroquinone and
 
silver lactate were prepared just before use in a vessel 
protected from light. 
4.2.4 Northern blot technique 
4.2.4.1 RNA extraction 
All glassware (i.e corex tubes, pasteur pipettes, etc.) were 
siliconized with 4% dichloro-dimethyl-silan in carbon 
tetrachloride, treated with DEP (diethylpyrocarbonate) (an 
RNAse inhibitor) and autoclaved. All buffers were treated 
with diethylpyrocarbonate and autoclaved before use. The 
ultra-homogenizer was dipped in 70% alcohol for 24 hours 
before use. Gloves were worn at all times. 
Wild type, Himalayan and albino mouse skins or epidermis were 
homogenized in 10 parts of NETS buffer (v/v) in a polytron 
ultra-homogenizer. The homogenate was treated with 10 µg/ml 
proteinase Kat 37°C for 30 minutes. RNA was extracted three 
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times with phenol/chloroform and precipitated with 0.3 M 
sodium acetate and 2~ volumes of ice cold absolute ethanol 
overnight at -2o·c. Precipitated RNA was spun down in a high 
speed centrifuge at 20 000 g for 20 minutes, then washed with 
70% alcohol and dried. RNA was resuspended in sterile water 
and its quantity determined at A260 . The purity was 
determined by the A260; 280 ratio. 
4.2.4.2 Purification of poly A+ mRNA on an Oligo-dT-
cellulose column 
The column containing± 1 ml of oligo-dT-cellulose was washed 
with 5 ml of NaOH (0.1 M). Total RNA (20 A260 units/ml) was 
dissolved in 1 ml high salt buffer (0.01 M Tris; 0.5 M NaCl, 
pH 7.5), then applied to the column (0.5 cm x 30 cm) 
equilibrated with 10 ml of the same buffer. In order to 
facilitate the binding of poly A+ mRNA, the effluent was 
loaded to the column twice before being washed with the high 
salt buffer until the reading at o.o. 260 ~ O. Bound poly A+ 
mRNA was eluted with the low salt buffer (0.01 M Tris-HCl, pH 
7.5) and precipitated with 0.3 M sodium acetate and 2~ 
volumes of ice cold absolute alcohol overnight at -2o·c. To 
encourage precipitation, transfer RNA was added to the 
mixture. 
115 
4.2.4.3 RNA blot analysis 
All procedures were performed according to Davis et al. 
(1986). 10 or 20 micrograms of total or poly A+ RNA were 
fractioned by electrophoresis on 1.1% agarose denaturing 
gels, blotted onto nitrocellulose filters (Hybond-N, 
Amersham) and baked for 2 hours at 80°C. The filters were 
prehybridized for 2 hours at 42°C in hybridization mix (40% 
formamide, 10% dextran sulphate, 4 x SSC, 0.02 M Tris (pH 
7.4); and 20 µg/ml salmon sperm DNA in water). They were 
hybridized for 24 hours at 42°C to either the tyrosinase pMT4 
cDNA (Shibahara et al., 1986) or the tyrosinase MTY811 cDNA 
(Kwon et al., 1988) cloned into pBR322 and pGEM respectively. 
After hybridization, the filters were washed in high salt 
mixture (20 ml 20 x SSC; 178 ml H2o; 2 ml 10% SDS) twice for 
20 minutes at room temperature followed by two 20 minutes 
washes in low salt mixture (1 ml 20 x SSC, 197 ml tt2o; 2 ml 
10% SOS). After the washing, filters were air-dried, loaded 




4.3.l Purification of tyrosinase 
A crude homogenate prepared from Bl6 melanoma cells was 
loaded onto a DEAE column and eluted as described in 
materials and methods. As shown in Fig. 4.1, unbound 
material formed a single small peak (peak "a"). When the 
bound material was eluted, it emerged as a larger sharp peak 
(peak "b"). Fractions with high protein content as measured 
at 280 nm were pooled and assayed for tyrosinase activity by 
measuring dopachrome formation at 475 nm. Figure 4.2 shows 
fractions from peak "a'' (i.e. A1 , A2 ,& A3 ) with low levels of 
tyrosinase activity, compared to those from peak "b" (i.e B1 
& B2 ) with higher levels of tyrosinase activity. The
se two 
samples from peak "b" were combined, concentrated against 
polyethelylene glycol and electrophoresed on a non-SOS gel. 
The DOPA staining of this gel revealed the presence of three 
tyrosinase isozymes (T1 , T3 and T4 ) (Fig. 4.3). In agreement 
with previous reports (Hearing et al., 1981; Hearing & 
Jimenez, 1987), the T1 isozyme was also found to have 
migrated further that T3 due to the presence of charged 
sialic acid sugar residues. Furthermore, these results are 
consistent with those of Hearing et al., (1981) since the T2 
isozyme which has been reported to be an artifact due to the 
















Fig. 4.1: Purification of tyrosinase. A crude homogenate 
from B16 melanoma cells was purified by DEAE ion exchange 
column chromatography as detailed in materials and methods. 
The homogenate was applied to the column with low salt buffer 
(20 mM Tris, pH 8). Bound material, eluted with high salt 
buffer (20 mM Tris, 0.3 M NaCl, pH 8), emerged as a single 













Fig. 4.2: Determination of tyrosinase activity of fractions 
eluted from the DEAE column. Fractions from peaks "a" & "b" 
(Fig. 4.1), as measured at A 28 were pooled and assayed for
 
tyrosinase activity. C, contra£ (homogenate substituted with 
phosphate buffer). A1 , A2 , & A3 , fractions from peak 
"a" 
with low tyrosinase activity; B1 & B2 , fractions from peak 
"b" with high tyrosinase activity. H, homogenate. 
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Fig. 4.3: Separation of tyrosinase isozymes by gel electro-
phoresis. Fractions with high tyrosinase activity (see Fig. 
4.2), pooled and concentrated against poly ethylene glycol 
(PEG 600), were electrophoresed on a non-denaturing 
polyacrylamide gel. The gel incubated with DOPA (1 mg/ml) in 
phosphate buffer (0.1 M, pH 7.4) shows dark bands 
corresponding to various tyrosinase isozymes; T3 , de novo 
form of tyrosinase, T1 , glycosylated form of tyrosinase and 
T4 , matured form of tyrosinase which complexes with 
melanosomal membrane components. 
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4.3.2 Molecular weight determination of tyrosinase 
Each of the three tyrosinase isozymes was cut out and 
electrophoresed on an SOS gel and proteins visualized by 
staining with Comassie blue. As shown in Fig. 4.4, all the 
isozymes were reasonably pure and formed two distinct bands. 
Using the Enzfitter non-linear regression data analysis 
programme (see materials and methods), the molecular weight 
of these isozymes were calculated to be about 77 kd and 42 kd 
(Fig. 4.5). 
4.3.3 Raising of a tyrosinase polyclonal antibody 
T4 tyrosinase isozyme purified from B16 me
lanoma cells (see 
materials and methods), was subcutaneously injected into 
guinea pigs and boost injected after 2 weeks. A week after 
the boost injection, sera were drawn and tested for the 
presence of tyrosinase antibodies using the western blot 
technique. No positive signal was detected suggesting the 
absence of tyrosinase antibodies. 
In view of the fact that guinea pigs failed to raise 
antibodies, rabbits were subsequently immunized with T1 and 
T3 isozymes, purified as described in paragraph 5.2.1.
2. It 
was also found that rabbits immunized with T1 and T3 failed 
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Fig. 4.4: SDS gel electrophoresis analysis of purified 
tyrosinase. Tyrosinase isozymes (see Fig. 4.3), were further 
electrophoresed on an SDS polyacrylamide gel and stained with 
Commassie blue (see materials and methods). Lane 2, T1 ; lane 
3, T3 ; lane 4, T. Note the presence of two d
istinct 
proteins; the moiecular weight calculation for each of these 
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Fig 4.5: Molecular weight determination of tyrosinase. 
Isozymes of tyrosinase (Fig. 4.3), analysed by SOS gel 
electrophoresis resolved into two proteins (see Fi g. 4.4). 
Distance migrated by proteins of molecular weight markers and 
also these two proteins were loaded on to Enzfitter non-
linear regression data analysis programme (Elsevier 1987), 
and used to calculate molecular weights. (*), molecular 
weight of the upper protein was calculated to be 77.82 kD, 
and that of the lower protein (*), was 42.66 kD. 
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to generate antibodies against these two isozymes and 
subsequent attempts to raise an antibody against the T4 
isozyme in rabbits were also unsuccessful. The implication 
of these results is addressed in the discussion. 
4.3.4 Quantitation of tyrosinase levels by immunoblot 
technique 
It was shown in Chapter 2 that tyrosinase activity in wild 
type skin, measured in the presence of cycloheximide was 1.6 
to 2.7 fold higher than in the Himalayan skin, suggesting 
that the activity of tyrosinase is regulated post-
translationally. To test whether this activity of tyrosinase 
correlated with its abundance, an anti-tyrosinase antibody 
(which binds active and inactive form of tyrosinase) was used 
to quantitate the total levels of this enzyme in the skins of 
wild type, Himalayan and albino mice. Crude homogenate 
proteins from skin were electrophoresed on a SDS gel slab 
(Fig. 4.6) and blotted onto nitrocellulose, then reacted with 
a tyrosinase antibody. As mentioned in paragraph 4.3.2, the 
sera drawn from both guinea pigs and rabbits did not give any 
signals when tested using the 4-chloro-1-naphthol/hydrogen 
peroxide staining procedure. In an attempt to solve this 
problem, a number of options were tried: (1) different 
antibody titers from 1:250 to 1:10), (2) Various blocking 
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Fig. 4.6: Electrophoresis of proteins on SDS polyacrylamide 
gels. Melanoma, albino, Himalayan, and wild type crude 
homogenate proteins were run on an sos gel slab and stained 
as described in materials and methods. Lanes 1-3, Bl6 
melanoma cells; lanes 4 & 5, albino; lane 5, Himalayan; lanes 
7 & a, wild type. 
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these attempts were unsuccessful, a more sensitive method 
(the immunogold staining procedure) was used. To our 
disappointment, this method was found to be too sensitive, 
which then made it impossible to distinguish between the 
genuine tyrosinase signal and the background reaction. Due 
to the lack of success to measure the levels of tyrosinase 
using our antibody, a tyrosinase polyclonal antibody which 
was a gift from Dr V.J. Hearing was finally used. Using this 
antibody, it was found that the total quantity of tyrosinase 
is higher in ·the wild type than in the Himalayan skin (Fig. 
4.7). The densitometric analysis showed that the wild type 
skin tyrosinase is twice that of the Himalayan skin (Fig. 
4.8). Interestingly, the albino tyrosinase, which is known 
to be inactive, did not react to this tyrosinase antibody. 
4.3.5 Determination of mRNA levels 
4.3.5.1 Hybridization of total RNA with pMT4 cDNA 
Results presented in the preceding section showed that the 
abundance of the wild type tyrosinase was twice that of the 
Himalayan, suggesting a translational control of this enzyme. 
The next logical step was to determine whether this abundance 
of tyrosinase was the result of transcriptional regulation. 
This was done by measuring the levels of endogenous mRNA 
transcripts in wild type, Himalayan, and albino mouse skins. 
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Fig. 4.7: Immunoblot quantitation of skin tyrosinases. 
Proteins prepared from crude homogenates and eletrophoresed 
under SDS denaturing conditions, were transblotted overnight 
onto nitrocellulose membrane at 100 mA, 14 V overnight. 
Transblotted proteins were incubated with polyclonal antibody 
3819 (1:250) (from Dr. V.J. Hearing) overnight, reacted with 
peroxidase-linked antirabbit secondary antibody (1:500) for 
an hour and incubated with 4-chloro-1-napthol/hydrogen 
peroxide mixture as described in materials and methods. B, 
black (wild type); H, Himalayan; A, albino; M, melanoma. 
Note that albino mutant shows no reaction, and also that the 
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Fig. 4.8: Densitometric analysis of immunoblotted 
tyrosinase. The total levels of wild type and Himalayan 
tyrosinase determined by immunoblot technique (see Fig. 4.7) 
were analysed on a Cliniscan densitometric equipment (Helena 
Laboratories, Texas) at 500 nm by horizontally scanning. The 
intregration of the two peaks showed that the amount of 
tyrosinase in the wild type skin is twice more than in the 
Himalayan skin. B, ~ack wild type; H, Himalayan. 
"' 
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RNA was extracted from mouse skins, fractioned on a 1.1% 
formaldehyde denaturing gel, transblotted to nitrocellulose 
membrane and hybridized to a ( 32 PJ-nick-translated 
radioactively labelled pMT4 cDNA (Shibahara et al., 1988). 
This experiment was repeated at least five times and it was 
consistently found that the pMT4 cDNA did not hybridize to 
RNA extracted from skin melanocytes of these mice. This 
failure to detect the signal was thought to be due to the 
probe that is not optimally labelled. To overcome this 
problem, the cDNA was then labelled using the multiprime 
method. Again, no signal was detected even if the gels were 
deliberately overloaded. However, when Bl6 melanoma cells 
were used as a source of RNA, a signal corresponding to the 
molecular weight of tyrosinase mRNA (about 2.3 kb) was 
detected (Fig. 4.9). 
4.3.5.2 Hybridization of poly A+ mRNA with pMT4 cDNA 
Unsuccessful attempts to detect mRNA levels extracted from 
mouse skins were thought to be due to the low concentration 
of mRNA since total RNA was loaded onto gels. In an attempt 
to overcome this problem, poly A+ mRNA was separated on an 
oligo(dT}-cellulose column and fractioned on a 1.1% 
formaldehyde denaturing gel, blotted and hybridized to the 
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Fig. 4.9: Northern blot analysis of melanoma mRNA hybridized 
to pMT4 cDNA. Total RNA was extracted from B16 melanoma 
cells, then transblotted to nitrocellulose membrane and 
hybribrized to a 32 P-labelled probe as described in materials 
and methods. Lane 1, 5 µg of melanoma RNA loaded; lane 2, 20 
µg of melanoma RNA loaded. Note that no hybridization signal 
was detected in lane 3 (RNA from fibroblast cells) 
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Unfortunately, three attempts to hybridize purified poly A+ 
mRNA to this probe were not successful. 
4.3.5.3 Hybridization of mRNA with MTY811 cDNA 
Due to futile attempts to detect tyrosinase mRNA using the 
pMT4 probe, the MTY811 cDNA (Kwon et al., 1988) was used as 
the next option. Total RNA extracted from the skins of wild 
type, Himalayan and albino mice was hybridized to the MTY811 
cDNA and processed as previously described. It was found 
that this cDNA also did not hybridize to the rnRNA extracted 
from the three mice. The next strategy employed to solve 
this problem was to eliminate RNA from acellular dermal 
debris by using the epidermis as a source of RNA extraction 
(see materials and methods). Under these conditions, a 
hybridization signai of- the expected length (i.e. 2.3 kb) was 
detected in all the three mice {Fig. 4.10). Although the 
levels of mRNA were low, densitometric scanning revealed that 
the level of RNA transcripts in the wild type skin was 1.2 
times higher than in the Himalayan mouse and 3 times more 
than in the albino mutant mice (Fig. 4.10) 
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Fig. 4.10: Northern blot analysis and densitometric 
quantitation of wild type, Himalayan and albino mRNA 
hybridized to MTY 811 cDNA. Total RNA extracted from the 
epidermis, transb~otted onto nitrocellulose membrane and 
hybridized to a 3 P-labelled probe (see materials and 
methods). The quantity of RNA in the wild type (W) skin was 
found to be 1.2- and 3-fold more than in the Himalayan (H) 
and albino (A) skins respectively. 
4.4 DISCUSSION 
4.4.1 Translational and transcriptional control of 
tyrosinase activity 
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There is substantial evidence that tyrosinase activity is 
regulated at a post-translational level (see Chapter 1). In 
Chapter 2 and 3 of this study, further evidence in support of 
this was provided. 
This chapter explores the possibility that in addition to the 
post-translational regulation of tyrosinase activity, 
translation and transcription might also play a role in the 
control of tyrosinase activity. If tyrosinase activity was 
exclusively post-translationally controlled and if the 
Himalayan tyrosinase was underglycosylated, similar 
quantities of newly synthesized T3 would be measured in both 
the wild type and Himalayan skins, but they would differ in 
the amount of T1 (glycosylated form). This is what Halaban 
et al. (1988) found using immunoprecipitation. In this study 
however, the amount of newly synthesized tyrosinase (M.W.~ 65 
kD, Fig. 4.7) of the wild type was shown by immunoblot 
technique to be twice that of the Himalayan mutant (Fig. 
4.8). The possible reasons for these different results could 
be due to either the different techniques or different 
specificities of the antibodies used. No tyrosinase was 
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detected in the albino skin, suggesting that this enzyme was 
not translated. 
At the same time as the above studies were being carried out, 
the levels of tyrosinase mRNA were measured to see whether 
transcription of the tyrosinase gene also played a role in 
the regulation of Himalayan tyrosinase activity. If 
tyrosinase activity was not regulated at the level of 
transcription, equal quantities of mRNA would be measured. 
Using the MTY811 cDNA, the levels of mRNA transcripts in the 
wild type skin were found to be 1.2- and 3-fold higher than 
in the skins of the Himalayan and albino mice respectively 
(Fig. 4.10). These results suggest that the transcription of 
the tyrosinase gene is yet another control mechanism that 
regulates the activity of skin tyrosinase in these mice. 
Interestingly, these findings conflict with reports that 
there are equal levels of mRNA in the skins and cultured 
melanocytes of the wild types (C57BL/6J & BlO.BR), Himalayan, 
chinchilla and albino mutant mice (Halaban et al., 1988; 
Shibahara, 1988; Takeuchi et al., 1988; Kwon et al., 1989). 
Why are these results different from those of the current 
study? A possibility exists that in the present study, the 
different levels of mRNA transcripts measured in the skins of 
these mice could be incorrect if different amounts of RNA 
were loaded on the gel. Since these results are considered 
as preliminary, the repeats of this experiment should include 
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an internal control probe to ensure that equal amounts of RNA 
are loaded. 
4.4.2 Raising of a tyrosinase polyclonal antibody 
In the initial attempt aimed at raising an anti-tyrosinase 
polyclonal antibody, purified T4 tyrosinase isozyme was 
injected into guinea pigs. On testing the serum for the 
presence of antibodies, it was found that this isozyme did 
not trigger an immune response in these animals. All 
subsequent attempts to raise a tyrosinase antibody against T4 
were not successful. As an alternative source of raising an 
antibody, rabbits that were immunized with the de novo (T3 ) 
and glycosylated (T1 ) forms of tyrosinase also did form 
antibodies against these isozymes. The question to answer 
is: Why is it that all attempts were unsuccessful? Futile 
attempts to raise tyrosinase monoclonal antibodies against 
the T1 and T3 isozymes were also reported by Tomita et al., 
(1985 and others, personal communication). As suggested by 
Hearing and Jimenez (1989), these findings confirm that 
precursor forms of tyrosinase are in general highly conserved 
in nature and as a result immunologically inert. Tomita et 
al. (1985) did, however, succeed to raise monoclonal 
antibodies against various epitopes of the T4 isozyme. 
Subsequent tests revealed that these monoclonal antibodies 
did not cross-react with T1 and T3 isozymes, but they reacted 
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with the neuraminidase-treated T4 isozyme. As suggested by 
these results, the immunogenic properties of mammalian 
tyrosinase seem complicated since they appear be independent 
of the presence of sialic acid residues, but on other post-
translational modifications of the enzyme which are currently 
not known. Whatever epitope is involved, it appears not to 
change drastically in various mammalian species. In support 
of this view is the fact that although the present study has 
failed to generate a tyrosinase antibody against T4 in guinea 
pigs, a chick anti-tyrosinase polyclonal antibody against 
this isozyme has been raised in these animals (Kidson et al., 
unpublished results). 
Other factors that make the raising of tyrosinase antibodies 
notorious are that: 
(a) The ultra-purification of tyrosinase is difficult due 
to the presence of sticky melanin which drags along 
contaminants which co-purify with the enzyme (Hearing & 
Jimenez, 1989). 
(b) Tyrosinase is generally a highly conserved protein in 
nature which, in addition, has a common molecular 
weight which makes it difficult to be isolated it from 
other housekeeping proteins (Hearing & Jimenez, 1989). 
(c) Due to the microheterogeneity of tyrosinase, the 
various isozymes are difficult to separate (Hearing et 
al., 1981; Hearing & Jimenez, 1989). 
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Considering these facts, it is therefore not a surprise that 
the present study has not succeeded to raise antibodies 
against various tyrosinase isozymes. 
4.4.3 Molecular weight determination of murine tyrosinase 
To date, there have been wide variations concerning the 
molecular weights of tyrosinase reported in the literature 
The reported molecular weight of the de novo form of 
tyrosinase ranges from 55 kD to 68 kD, meanwhile that of the 
matured form ranges from 70 kD to 94 kD (Burnett, 1971; 
Pomerantz, 1973; Hearing et al., 1978, 1981; Tomita et al., 
1985; Fuller et al., 1987; Halaban et al., 1988; Jimenez et 
al., 1988; Hearing & Jimenez 1989; Mc Ewan et al., 1988; 
Yamasaki et al., 1988; Halaban & Straight, 1989; Moody et 
al., 1989). 
In the light of these differences, the present study has 
investigated this issue by determining the molecular weight 
of tyrosinase isolated from Bl6 melanoma cells. To carry out 
this investigation, tyrosinase isozymes were purified as 
described in materials and methods, the separated on a non-
SOS gel and localized by DOPA staining {Fig. 4.3). Further 
electrophoresis of these isozymes under SOS denaturing 
conditions consistently revealed the presence of two proteins 
• 
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whose molecular weights were calculated to be 77,82 kD and 
42,66 kD (Fig. 4.4). The molecular weight of the 77 kD 
protein seems reasonable, since it corresponds to the average 
molecular weight of the matured form of tyrosinase, but the 
nature of the 42 kD protein remains to be elucidated. The 
possibility that this could be a contaminating protein can be 
discounted, since it was present in the T1 , T3 , and T4 
isozymes, which originated ·· r-om different positions on the 
gel slab (Fig. 4.3). Furthermore, this protein may not 
represent partially glycosylated tyrosinase, since the de 
novo form of mammalian tyrosinase, which is unglycosylated, 
has an apparent molecular weight of about 55 kD (Hearing et. 
al., 1981). A recent study by Halaban et al. (1988) has 
provided some insight relating to how this 42 kD protein 
could arise. In this study, the 42 kD and 47 kD proteins 
were predominantly immunoprecipitated in the chinchilla 
melanocytes in addition to the matured form of tyrosinase. 
The 47 kD protein was also immunoprecipitated in the wild 
type (BRlO.BR) melanocytes which were left for longer in the 
absence of protease inhibitors. These results suggest the 
o} 
existence~protease-dependent cleavage products of the 
matured form of mammalian tyrosinase which is also present 
in the chinchilla mutant. On the basis of these reports by 
Halaban et al. (1988), it is concluded that even in B16 
transformed melanocytes used in this study, the 42 kD is the 
cleavage product of the 77 kD matured form of tyrosinase 
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which did not change when these cells were transformed. 
However, this proposition needs to be substantiated further 
by experimental work. 
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CHAPTER V 
GENERAL DISCUSSION AND CONCLUSIONS 
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Differentiation is a process by which cells and tissues 
become different from one another by virtue of their ability 
to synthesize specific structural and functional end 
products. The synthesis of these end products is directed by 
the activity of tissue-specific genes. The factors that 
regulate the ·switching on' of eukaryotic genes are now 
beginning to emerge. The process of differentiation is very 
complex indeed and cannot be fully explained by differential 
gene activity per se, since the parameters that regulate the 
repression of those unexpressed genes are still not 
understood. Thus, it appears that we are still far from 
understanding the complex events that direct the 
differentiative pathway of cells. 
Those active genes that are normally expressed in a 
particular differentiated system are characterized by a 
unique nucleotide sequence of RNA which is the result of 
accurate transcription of the particular gene. The 
production of proteins in differentiated cells is further 
regulated at translational and post-translational levels. 
Any gross deviations in any of these regulatory mechanisms or 
in the normal sequence of the gene itself, may result in a 
mutation or transformation of that particular cell or tissue. 
These mutant and transformed cells are in turn valuable 
'tools' that may be used in understanding the complex 
mechanisms that operate in differentiated cells. 
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The present study has made use of a normal, mutant and 
transformed melanocytes to explore the mechanisms that 
regulate the synthesis of melanin. The first agent used in 
this study to investigate the regulation of melanin synthesis 
was melanocyte stimulating hormone (MSH). This study was 
initiated as a consequence of an earlier observation made i n 
our laboratory that the injection of a-MSH into the skins of 
Himalayan living mice resulted in the darkening of the coat 
color. This finding suggested that the hormone could 
override the inhibitory effect of temperature on the activity 
of the Himalayan tyrosinase. In order to verify this 
subjective evaluation of the effect of a-MSH, an assay was 
established that made it possible to measure the activity of 
tyrosinase in .the presence of the hormone. 
Using this skin culture radiometric assay, it was possible to 
show that at 37°C, MSH (10-9 M to 10-4 M) activated both the 
wild type and the Himalayan tyrosinase in a dose-dependent 
manner. This activation of the Himalayan and wild type 
tyrosinase by a-MSH was found to be similar even in the 
presence of cycloheximide, suggesting that the hormone was 
acting at a post-translational level. a-MSH did not, as 
expected activate the albino tyrosinase. By increasing the 
concentration of a-MSH one would expect to reach an optimal 
concentration beyond which no further increase of tyrosinase 
activity would occur. Considering the situation in vivo, 
where MSH is transported in blood vessels and diffuses from 
142 
the sub-epidermal vessels to melanocytes, it is possible to 
saturate MSH receptors at a lower concentration of the 
hormone than in our skin culture assay where MSH supply to 
melanocytes relies on the diffusion through agar and the 
dermis. This might explain why it was not possible to reach 
a saturating concentration. 
Despite this technical limitation, it has been possible to 
show a dose-dependent activation of wild type and Himalayan 
tyrosinase in culture. Is there a link or relationship 
between activation of the Himalayan tyrosinase by low 
temperature and the activation of this enzyme a-MSH? It has 
recently been shown that in the leopard frog, Rana 
chiricahuensis, the lowering of the skin temperature from 
2s·c to 1o·c results in its darkening (Fernandez & Bagnara, 
1989). By radioimmunoassay technique, it was further shown 
that at 1o·c, the amount of a-MSH in the blood plasma of this 
frog was 62% higher than at 2s·c. Although these findings 
were demonstrated using a cold-blooded vertebrate, they raise 
the possibility that in vivo, temperature could activate the 
Himalayan tyrosinase by triggering the release of MSH. 
How does a-MSH activate the Himalayan tyrosinase? This may 
be explained in terms of two theories. Firstly, the presence 
of tyrosinase inhibitors has been shown in the Himalayan skin 
(Kidson & Fabian, 1981) and other pigment cell types (Quevedo 
& Mishima, 1960; Chian & Wilgram, 1967; Korner & Pawelek, 
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1977; Fuller et al., 1988). The removal of a tyrosinase 
inhibitor by phosphorylation-dependent events has been 
demonstrated in S91 mouse melanoma cells (Korner and Pawelek, 
1977; Pawelek, 1989). It is possible therefore that a-MSH 
might act to remove the Himalayan inhibitor via 
phosphorylation (see Fig. 5.1) 
The second theory that could account for the stimulation of 
the Himalayan tyrosinase activity in the presence of a-MSH 
involves the glycosylation of this enzyme. The Himalayan 
tyrosinase has been shown to be deficient in N-linked 
glycosylation (Halaban et al., 1988). It was shown in this 
study that the Himalayan tyrosinase has a reduced ability 
incorporate tritiated mannose and N-acetylglucosamine and 
that the bulk of immunoprecipitated tyrosinase corresponds to 
the molecular weight of an underglycosylated enzyme. The low 
molecular weight form of tyrosinase has been shown to be 
predominant in pigment cells with low tyrosinase activity and 
is degraded faster than the fully processed tyrosinase in 
cells with high enzyme activity {Halaban, 1984). The fully 
glycosylated tyrosinase is abundant and correlates with 
melanin content in normal human melanocytes derived from 
Caucasian and Black foreskin, further confirming the role of 
glycosylation on melanin synthesis (Halaban & Straight, 
1989). Thus, reduced activity of the underglycosylated 
Himalayan tyrosinase is thought to be caused by the 
susceptibility of this enzyme to proteolytic degradation. In 
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the light of the fact a-MSH can activate the Himalayan 
tyrosinase, a possibility therefore exists that the hormone 
might do so via glycosylation and thereby making this enzyme 
more stable and active (see Fig. 5.1 & Appendix) 
In order to investigate whether a-MSH activates tyrosinase by 
enhancing glycosylation, the effect of the hormone on mannose 
incorporation was examined. Due to difficulties involved in 
the culturing of normal mouse melanocytes and also the 
inability to control for sugars incorporated into glycolipids 
in cultured skin, it was impossible to directly test this 
hypothesis on the Himalayan mouse. In the light of these 
problems, the effect of a-MSH on the incorporation of mannose 
was investigated using B16 mouse melanoma cells. 
As a preliminary step, it was necessary to confirm that our 
stock of a-MSH could activate melanoma tyrosinase and then 
under the same experimental conditions measure the 
incorporation of tritiated mannose. B16 melanoma cells were 
cultured for 24 hours in DMEM containing MSH (2 x 10-7 M) and 
with or without cycloheximide. a-MSH was found to stimulate 
a 9-fold increase of tyrosinase activity above control in the 
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Fig. 5.1: Scheme showing the possible mechanisms of a-MSH 
action. Note that mechanism a shows the phosphorylation and 
inactivation of a tyrosinase inhibitor by a-MSH, while 
mechanism b shows an alternative mechanism of the hormone 
which involves glycosylation. a-MSH, melanocyte stimulating 
hormone; GTP, Guanosine triphosphate; c-AMP, cyclic -3,5-
adenosine monophosphate. 
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increase (i.e. 1.3-fold) in the presence of cycloheximide 
(Fig. 5.2). Subsequently, the effect of a-MSH on D-[2-3HJ-
mannose incorporation was investigated. If a-MSH promotes 
glycosylation, which is an exclusively post-translational 
event, it should do so even when protein synthesis is 
blocked. It was found that a-MSH increased the incorporation 
of tritiated mannose 1.3-fold above control in the absence of 
cycloheximide, whereas in the presence of this protein 
synthesis inhibitor, the incorporation of mannose was 3.5-
fold lower than in the control (Fig. 5.3). These results 
suggest that the post-translational activation of tyrosinase 
by a-MSH does not involve glycosylation directly. Thus, the 
hormone may act to increase the de nova synthesis of 
tyrosinase molecules which are then glycosylated. Since a-
MSH was shown to activate the Himalayan tyrosinase post-
translationally (Chapter 2), it is unlikely that the hormone 
might exert its effect via glycosylation in this mutant. 
In addition to the proposal that the Himalayan tyrosinase is 
under-glycosylated, a point mutation has recently been 
identified in this mouse (Kwon et al., 1989). In this study, 
the analysis of the Himalayan tyrosinase cDNA has revealed 
that this mutant contains an A to G change at nucleotide 1259 
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Fig. 5.2: The effect of a-MSH on B16 melanoma tyrosinase 
activity. Melanoma cells were cultured for 24 hours in DMEM 
containing a-MSH (2 x 10-7 M) and with or without 
cycloheximide (0.25 µg/ml). Tyrosinase activity was measured 
using the in vitro radiometric assay. This experiment was 
repeated twice with similar results. Each value represents 
the mean of two measurements± S.D. The values are 
significantly different from control at P < 0.05. C, control; 
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Fig. 5.3: The effect of a-MSH on mannose incorporation. Bl6 
melanoma cel1s were cultured for 24 hours in DMEM containing MSH (2 x 10- M) and with or without cycloheximide (0.25 
µg/ml). D-[2-3HJ-mannose was added in the culture medium to 
a final concentration of 0.5 µCi/ml. Cells were collected 
with 0.05% EDTA-0.02% trypsin. The cell lysate was 
micropipetted onto GFC Whatmann discs, washed twice in 10% 
trichloroacetic acid for 5 minutes, then rinsed in 90% 
ethanol for 5 minutes and twice in acetone for 5 minutes. The 
discs were air-dried and counted in 5 mls of toluene 
scintillator (Parkard) in a Parkard Tricarb liquid 
scintillator. This experiment was repeated twice with 
similar results. Each value represents ·the mean of two 
measurements± S.D. a-MSH, melanocyte stimulating hormone; 
cycl., cycloheximide. 
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residue at amino acid 420. Histidine residues are known to 
be copper binding sites (Lerch, 1983), which affect the 
activity of this enzyme {Martinez et al., 1987). Since not 
all amino acid substitutions have destabilizing effects on 
enzymes (Alber, 1989), the histidine substitution can only 
affect the Himalayan tyrosinase activity if it is located at 
a critical position such as at or near the active site. The 
altered histidine of the Himalayan tyrosinase has been shown 
by Kwon et al. {1989) not to be proximal to the active site, 
but to be located next to the transmembrane region. 
Furthermore, only Hist 191 and Hist 200 of the mouse 
tyrosinase are involved as copper ligands at the active site 
of this enzyme {Lerch, 1988). Thus, the amino acid 
substitution may not affect the activity of the Himalayan 
tyrosinase directly, but can change the conformation so that 
the enzyme has a higher affinity for inhibitors (Kidson & 
Fabian) or is underglycosylated (Halaban et al., 1988) or 
inappropriately transported to melanosomes. 
In conclusion, the results presented in this thesis have 
shown that in addition to the post-translational control 
mechanism, the activity of wild type and Himalayan 
tyrosinases is regulated at the level of translation and 
transcription. In particular, they show that reduced 
activity of the Himalayan tyrosinase at normal body 
temperature may be due to the lower expression of the 
tyrosinase gene. Since the transcription of eukaryotic genes 
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is influenced by regulatory elements with the promoters 
(Johnson & Mc Knight, 1989), it is possible that the 
Himalayan tyrosinase gene has a temperature-sensitive element 
within its promoter which somehow inactivates the gene at 
normal body temperature. Analysis of the promoter activity 
of the wild type and Himalayan tyrosinase genes might shed 
some light on this idea. 
Having attempted in the current study to use a melanocyte to 
shed some light on the process of differentiation, where are 
we in the understanding of this complex process? Although 
this study has indeed provided some insight on the regulation 
of melanin synthesis, a glance at living cells under the 
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1'-lelancocyte stimulating hormone (l'-ISH) controls melanogenesis in the 
integument of vertebrates, although its median ism of action on tyrosinase, 
the rate limiting enzyme in this pathway, is still unclear . Numerous reports 
suggest that 1'1SH increases tyrosinase activity by activating pre-existing 
enzyme. In contrast to this view, studies with protein and RNA inhibitors 
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